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Development and Validation of an Instrument to Predict Non-Adherence to Medical Treatment
Regimens

Evaluation of the Health Adherence Behavior Inventory (HABIT) is described with data
pertaining to reliability and validity. The instrument was originally developed for use in a primary
healthcare setting, to support the early identification of patients who are at risk for poor health
outcomes and complications of chronic disease because of non-adherence to their healthcare
provider’s instructions. The items were refined from the original HABIT (DiTomasso, 1997) and
drawn from various sources, including health risk assessments, health screening questionnaires, and
nationally accepted standards for disease treatment and prevention.
The questionnaire consists of 50 items, 39 of which appear to load on one factor. Items were
analyzed, revealing two clusters, which yielded one Main Factor (Prevention Factor). This factor
represents positive health behaviors that have demonstrated a correlation with reduced risk for
negative health outcomes. These behaviors address one domain of the multifaceted problem referred
to as non-adherence.
With respect to construct validity, the questionnaire correlated significantly with the widely
used and reliable Health Risk Assessment developed by Lifestyle Directions, Inc. The strong
correlation with an established Health Risk Assessment suggests promise for further refinement of
the scale, offering a briefer alternative to full risk assessment. Through additional research, it is
anticipated that a more comprehensive set of questions may uncover other key domains that offer
valuable insight into the prevention and the treatment of non-adherence.
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CHAPTER 1
INTRODUCTION

The Cost of Non-Adherence
It is estimated that in 2003, over 3 billion prescriptions were written by physicians in the
United States. Researchers estimate that between 12% and 22% of these prescriptions have never
been filled. Another 12% were filled but were not taken, and of those taken, better than half would
have been discontinued within 1 year. (Ellis, et al. 2001) The consequences of this problem are
staggering, yet a single solution has yet to be clearly identified. Non-adherence with medical
treatment regimens is recognized as a significant healthcare issue and a risk factor for poor health
outcomes (McDermott, 1997). Creer (1996) refers to adherence as the “congruence between
patient behaviors and advice or instructions provided by health care providers”. For the purposes of
this discussion, non-adherence will be defined as the absence of voluntary involvement by a patient
in a mutually acceptable course of behavior to produce a desired preventive or therapeutic result
(Meichenbaum & Turk, 1987). Examples of such behavior would include failure to enter into
and/or to continue a treatment program, keeping appointments, taking correct medications, adopting
life-style changes, and following physician’s advice.
Non-adherence with long term medication regimens has been estimated as low as 42% and
as high as 60% (some higher), with an average of approximately 50% across disease states (Sackett
& Snow, 1979; Haynes, 1985; Bayer Institute for Health Care Communication, 1996;
Meichenbaum & Turk, 1987; Dean & King, 1999). The Center for Health Policy Studies estimates
that as many as 23% of nursing home admissions and 10% of hospital admissions in the United
States each year may be due solely to non-adherence with prescribed medications. (Wegner, et al.
1995; Sung, et. al. 1998) Adherence to asthma regimens, for example, has been estimated as
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standing between 2% and 100%, with an overall rate across studies at less than 50% (Milgrom, H.,
et al. 1996; Creer, 1996). This is even more distressing in the face of pharmacologic advancements
in the treatment of this illness which should improve patient management; instead of improvement,
there is the unexplained increase in morbidity and mortality, which experts suspect may be closely
tied to poor adherence (Creer, 1996).
The impact of arthritis and related diseases is another example of enormous health care costs
for individuals, their families, and the nation. Every year, arthritis results in over 39 million
physician visits and hundreds of thousands of hospitalizations, at an estimated cost of $15 billion.
By the year 2020, experts estimate that 60 million Americans, or nearly 20% of the population, will
be affected, and some 11 million will be disabled as a result (U.S. Dept. of Health and Human
Services, Centers for Disease Control and Prevention, 1998). Much of this could be moderated
through the adoption of healthier lifestyles or through the use of therapy, as prescribed by a
physician.
The scenario is equally problematic in the area of heart disease. According to the Office of
Inspector General (1990), drug non-adherence with treatment for cardiovascular disease results in
125,000 avoidable deaths each year in the United States alone. In this report, Daniel Gerner,
chairman of the Healthcare Compliance Packaging Council in Washington, D.C., reported that rates
of compliance are about 46% among asthmatics, 33.5% for patients on antibiotic therapies and 53%
among hypertensive patients. Unfortunately, just over half of hypertensive patients are on any kind
of therapy at all. The American Heart Association (AHA) reported that hypertension alone killed
42,565 Americans in 1997 and contributed to the deaths of about 210,000. (AHA, 1999). Since
then these numbers have continued to rise. The cost of cardiovascular diseases and strokes in the
United States in 2005 is projected at nearly $393.5 billion, more than 3 times the estimated costs in
1994. This figure includes health expenditures (direct costs, which include the cost of physicians
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and other professionals, hospital and nursing home services, the cost of medications, home health
and other medical durables) and lost productivity resulting from morbidity and mortality (indirect
costs). In the case of hypertension the total cost is estimated at $59.7 billion. (AHA, 2003).
The cost of chronic illness in the United States is tremendous, in terms both of quantitative
and qualitative consequences. The Task Force for Compliance in 1994 estimated that the combined
direct and indirect costs of non-compliant patients for 1993 was over $100 billion, and in excess of
$8.5 billion in hospitalization and physician costs; non-compliance was also responsible for over
10% of all hospital admissions (McCarthy, 1998). More recent studies reveal no significant
improvements in this area. Experts conservatively estimate that half of the 2 billion prescription
medicines dispensed in 1998 were not taken as prescribed (Clepper, 1992; McCarthy, 1998).
Maintenance therapies for asymptomatic conditions are especially prone to non-adherence.
Other forms of non-adherence are not as well documented, but a 1985 study by Haynes
found that 50% of patients did not follow referral advice, 7% did not keep follow-up appointments,
and 50% suffering from chronic illnesses dropped out of treatment within one year. Some clinical
studies suggest that patients who fail to adhere to treatment regimens increase health care spending
in the U.S. by $7 billion to $10 billion per year simply in increased hospital and physician costs
(Cramer & Spilker, 1991). In 1994, the direct annual costs attributed to noncompliance alone were
estimated at $45 billion by Center for Health Policy Studies (Sung, et. al. 1998).
The medical community, health maintenance organizations, and payers have called for better
ways to help patients adhere to prescribed regimens and behavior changes (Guico-Pabia, C. et al.
2001); (Eraker, Kirscht, and Becker, 1984). Many attempts have been made to develop methods to
enhance compliance with various interventions. Unfortunately, the first evidence of non-adherence
often occurs when the patient returns to the physician because the condition or illness has not
improved or has worsened. Only then can the physician even begin to suspect non-compliance
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(McCarthy, 1998). To date no comprehensive instrument is available to differentiate reliably, in
advance of treatment, between patients who will be compliant and those who will not. Such an
instrument would offer healthcare providers the opportunity to intervene earlier in the treatment
process by providing insight about potential barriers to adherence. In anticipation of problems the
patient may encounter, the physician could take immediate steps to lower, potentially, the patient’s
risk of complications, to reduce side effects and associated costs of additional or stronger
medication, to raise the individual’s quality of life, and improve therapeutic outcomes (Frederikson,
1995).

Non-adherence and Health Behavior Theories
Numerous studies which examine non-adherence have been conducted, with varying degrees
of success. The overwhelming majority of these studies have been narrowly focused, examining
between one to five specific factors, such as family or social support, patient education,
provider/patient interaction, treatment complexity and dosing, access barriers, intelligence, and selfefficacy, among others.
Attempts to develop a theory of non-compliance have also generated several studies,
including one example postulated by Fogarty (1997), which is referred to as the Reactance Theory.
This theory draws upon the concept of psychological reactance to explain patient non-compliance
with medical treatment. A perceived threat by an individual to his/her freedom generates a
motivational state aimed at recapturing the affected freedom and preventing the loss of other
freedoms. Thus the patients’ perceptions of threats to their freedom or control may induce noncompliance. In her work, Fogarty proposed three macrolevel non-compliance patterns, including
length, complexity, and type of medical regimen. She concluded that high rates of non-compliance
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with complex and/or lengthy regimens may be at least partially explained by reactance theory, and
she suggested, further, that there might be implications for examining the physician/patient
encounters more closely. Interventions, she theorized, might be productive if the patients felt more
in control of their conditions.
In their review of the relationship between Social Cognitive Theory and health behavior,
Baranowski, Perry, and Parcel (1997) summarize the constructs of Mischel (1973) and Bandura
(1977) in a discussion of non-adherence, together with proposed intervention strategies. Some
examples of these constructs include environment, expectations, self-control, self-efficacy,
reinforcements, and so forth. They speculate that through the systematic identification of relevant
domains or constructs associated with non-adherence, and the application of these domains to
individual responses and behaviors, healthcare providers are better positioned to facilitate positive
changes within their patient populations, and are able to do so at an earlier point in the treatment
process. The components of Social Learning Theory propose that the patient will not actively
pursue change or positive health behaviors if he/she does not reasonably expect the ability to be
successful. Thus self-efficacy is an important concept with respect to predictive change. Smoking is
a negative health behavior that illustrates this concept. (Glanz, Lewis, & Rimer, 1990). Many
people become discouraged after failed attempts to quit, which in turn decreases the likelihood of
future attempts.
In a discussion on the origins of the Health Belief Model, Rosenstock (1990) suggests that it
is important to differentiate between intrinsic (an internal reason) and extrinsic (an external reason)
motivations for change. They hypothesize that self-efficacy is a stronger predictor of behavioral
change among those with strong a perception of threat and a recognition of the benefits of taking
recommended health actions. “Perceived threat”, they stated, “is a sequential function of perceived
severity and perceived susceptibility”. People who deny their conditions will fail to acknowledge
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the severity of the situations realistically, which in turn will affect their readiness to change. The
Health Belief Model presumes that a trigger will initiate other variables and behaviors into motion
(Quine, Rutter, and Arnold, 2000). One of the considerations believed to play a role in the patient’s
actions include not only the perceived benefits of the treatment or behaviors, but also the barriers to
obtaining or performing the necessary behaviors. Barriers such as cost, convenience, and impact on
self and family may negatively weigh in on the cost-benefit analysis of compliance.
It is hypothesized that many factors can influence a patient’s ability and willingness to
comply with a specific treatment regimen. For example, adherence with medications is found to
decrease under certain circumstances, such as the presence of side effects, perceived efficacy, the
duration of medication use, the complexity of the regimen, and the relative cost of medications
(Creer and Levstek, 1996). Inadvertently poor (??) interactions between physicians or medical staff
and patients or parents may also result in incomplete or inadequate instruction, which in turn leads
to failure to understand side effects or to misperceptions that foster non-adherence (Creer and
Levstek, 1996). Other negative factors influencing patients may include lack of social support,
memory decay, previous experiences, social stigma, apathy, co-morbidities (especially depression),
lack of perceived benefits, and a general lack of reinforcement contingencies (Creer and Levstek,
1996).

Research identifying causes of non-compliance attempts to reveal those who are

liable to be non-compliant. Much of this research is based upon models which were developed to
explain health behaviors. For example, the previously mentioned Health Belief Model (HBM)
proposes that individuals are more or less likely to adhere to a treatment regimen if they believe that
1) there is a threat to their health, 2) they are personally susceptible to negative consequences, 3)
they have some control in averting a negative health consequence, and 4) they do not perceive
barriers to performing the desired behavior (Wiebe and Christensen, 1997; Tiedje and Kingry,
1992). The HBM, which dates back to the early 1950s, is one of the earliest models developed to
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help explain health behavior and it is still one of the most influential and widely used approaches
today. In 1993 DiMatteo, (et al.), studied the adherence of cancer patients; this was done in an
effort to develop a scale to address elements of patients’ adherence. The Adherence Determinants
Questionnaire (ADQ) assessed 7 elements of patient’s adherence to medical treatment and
prevention, including perceptions of interpersonal care, beliefs about susceptibility, beliefs about
severity, perceived utility of adhering, perceived subjective social norms for adhering, intentions to
adhere, and perceptions of supports available, including absence of barriers. Past adherence and
health value were also assessed. In field settings, intentions to adhere were most highly correlated
with the perceived utility of adhering. Self-reported and objective measures of adherence were most
strongly correlated with the presence of supports and the absence of barriers.
In a study of 597 women with early stage breast cancer, Fink, et al. (2004) found that 17%
of the patients stopped taking tamoxifen during the 2 year follow-up period. Of these, 68% stopped
taking it within the first 12 months. Examining the subjects’ beliefs about therapy, the authors
concluded that the ways in which the women perceived the risks and benefits of therapy were critical
for sustaining adherence, and they recommended interventions designed to educate patients about
the benefits and risks to discontinuance.
Although these models of beliefs and perceptions of severity and susceptibility have been
frequently studied and show promise, to date they have not been shown to correlate consistently with
variances in health related behaviors. (Abraham and Sheeran, 2000)
Another model, based upon structural theories of personality, is the Five-Factor Model (17),
incorporated in the NEO Personality Inventory. This instrument has not been well studied, but
purports to identify five dimensions of personality, including Extraversion, Agreeableness,
Conscientiousness, Neuroticism, and Openness to Experience. Of these, only Conscientiousness
appears to offer potential as a predictor of health behaviors, though this is still only speculation.
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Other researchers have attempted to evaluate adherence by patients with chronic diseases, utilizing
other personality questionnaires, such as the Sixteen Personality Factor Questionnaire (16PF). Such
research has demonstrated limited success with similar constructs, such as Locus of Control and
Self-Control (Wiebe and Christensen, 1997).
Self-Regulation Theory proposes that a patient’s adherence behavior is closely tied to the
physical symptoms and illness memories which interact in a way that triggers the compliance
process. (Leventhal, 1984). To illustrate, in a study of kidney transplant patients, Siegal and
Greenstein (1998) reported that the patients most likely to adhere to treatment regimens were
“convinced” that their medications must never be delayed or missed, that they last in the body for
less than 1 day, and that their physical symptoms interfered with the things they needed to do. In
contrast, the low, or “partial-compliers”, did not believe that the medication was essential, that it
lasted longer in the body, and they perceived their physical symptoms to be milder than those in the
“compliers” group.
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The Multiattribute Utility Theory speculates that actions depend upon subjective values of
specific outcomes. The individual considers the probabilities and consequences of alternative
decisions, along with the relative importance of each consequence to the final decision. Ultimately
these factors influence the person’s actions. In the case of alternative health behaviors, it is
speculated that the Multiattribute Utility Theory model has the ability to differentiate adherent and
non-adherent patients. However few studies have been conducted to evaluate this theory in applied
health decisions. (Carter, 1990) The Multiattribute Utility Theory is best illustrated in consumer
purchasing behavior. Buying a car with airbags, for example, may cost more than the consumer
would like to pay, and the purchaser must consider the probability and consequence of deciding to
pay more or forego the option.
Yet another theory on behavior change is the Attribution Theory developed by Weiner in
1986. Similar in theme to other health psychology models, this theory focuses on the human need or
desire to understand or explain adverse events. People want to make sense of their world and
attempt to do so by looking for causal relationships. In 2000, Byrns studied low back pain in the
garment workers industry. He found that those employees who attributed their pain to internal
causes, such as knowledge of back safety, tended to feel less distress than those who believed the job
itself was too difficult (external attributions). According to Byrns, this belief of the former that their
pain could be reduced through their own actions reinforced the workers’ motivation to adopt
healthier behaviors based on a perception of their control of their particular circumstances.
Other theories that have been proposed to contribute greater understanding to the reasons for
non-adherence include components similar to those already mentioned. For example, The Protection
Motivation Theory framed by Rogers in 1975 underscores the persuasive value of fear
communications; together with perceived self-efficacy, these may lead to cognitions and motivation
for coping mechanisms and decisions to engage in protective behavior. A practical illustration of
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this theory is the relatively higher treatment compliance rate believed by some to be observed in
patients with HIV. In Western nations, the fear of HIV, along with mass communications related to
prevention and treatment, were believed at one time to contribute to greater use of condoms in high
risk populations and with better compliance with treatment among those already infected and
diagnosed. (Catz, et al., 2000) Recent literature reveals mixed results.
Consumer Information Processing Theory (Rudd, et al. 1990) focuses on consumer choice
and the availability of relevant information. This model supports the idea that consumers’ decisions
are directly related to each individual’s ability to process information (capacity), in combination
with motivation, attention, and decision rules and processes. The quality of the information and the
consumer’s internal cost-benefit analysis is tied to other constraints such as time, difficulty, etc. in
the decision making process. At face value, this appears to make sense when applied to decisions
such as financial investments, or the support of a particular political candidate. Unfortunately, when
applied to decisions about healthcare, this model may not always serve the patient’s best interests,
particularly if he/she does not take the time necessary to make a fully informed decision. This may
be related to perceived difficulty in understanding the choices in healthcare decisions, pointing again
to the importance of the physician’s role in properly educating his/her patient.
Within the last two-plus decades, revised versions of older theories have also surfaced.
These include the Media Advocacy Theory (1990); the Precaution Adoption Model (1993); and the
Transtheoretical Theory (1982-1983). Of these, the Transtheoretical Theory has received the most
attention nationwide by stakeholders in the healthcare industry. DiClemente and Prochaska
developed this model, with the initial focus primarily on how people change addictive behaviors
(although precursors of this stage model can be found as early as 1966). (Prochaska, DiClemente
and Norcross, 1992). The premise is that all individuals go through various phases when making
changes and that this process has certain,(?) defined stages related specifically to the person’s
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readiness to change. These dimensions of the change process are delineated in five phases,
beginning with precontemplation, contemplation, preparation, action, and maintenance. In the
precontemplative stage the person has no intention to change in the foreseeable future. As individual
awareness is raised and the person initially considers change, he/she has entered the contemplation
stage. Thus in the case of health behaviors, a good illustration is the person who smokes cigarettes.
This is the behavior most closely studied and most frequently referenced in literature on the
transtheoretical model. According to proponents of the theory, the smoker who thinks seriously
about quitting, and in fact begins to investigate methods to quit, has entered the contemplation
phase. Once he/she joins a smoking cessation program, buys the nicotine patch, or other substitute,
the person has entered the preparation phase. Actually using the patch or participating in smoking
cessation classes and stopping this behavior constitute the action phase. (Norcross, et. al., 1989) A
study by O’Connor, et al. (2004) was designed to test the hypothesis that patient readiness to change
predicts future changes in glycemic control in adults with diabetes. The results presented readiness
as an independent predictor of change in HbA(1c) for patients with high functional health status, but
not for patients with low functional status. The authors recommended judicious use of the readiness
to change assessment as a potential to improve care. Considerable controversy exists over the lack
of standardization of measures, of timeframes for stages, and of the exact predictive value of the
model. However, the theory has many supporters and several have adapted the model to specific
uses, especially in healthcare, in which efforts to influence health behavior changes are becoming
increasingly aggressive in response to rising costs. Examples include a variety of disease
management programs which incorporate one-on-one counseling interventions, such as patient
reminders and education, and low/no cost treatment, each designed for the patient’s specific “phase”
in the transtheoretical process of change.
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Although specific factors are speculated as contributing to non-compliance, the issue is
generally considered to be a multi-factorial phenomenon and to date no comprehensive assessment
tool is available to identify prospective patients at risk for non-adherence. Various theories,
including those underlying the development of models such as the Health Belief Model (HBM),
provide a valuable foundation for examining the correlates of poor adherence; however, the problem
is not consistent across patients, and numerous factors may operate simultaneously in any patient at
any point in time. This is a significant challenge because the problems cannot be adequately or
efficiently addressed until the underlying causes are identified and targeted.
Non-adherence and related Psychological, Social and Clinical Variables
From the Journal of Health Psychology, DiMatteo (2004) reported that a meta-analysis of
patient adherence and social support has revealed a significant relationship between structural or
functional social support and patient adherence to medical regimens. Factors such as practical,
emotional and unidimensional social support, family cohesiveness and conflict, marital status, and
living arrangements were examined. Practical support substantiated the highest correlation with
adherence; marital status and living arrangements had modest correlations
Sanz, Constable, Lopez-Ibor, Kemp, and David (1998) studied insight scales and their
relationship to psychopathological, social, and clinical variables. Their results supported the theory
that psychopathology and clinical variables, particularly those related to insight, are related to
attitudes towards treatment and subsequent compliance. The implications for those with mental
health issues are evident.
In a recent study by Tucker, et al. (2004), the authors examined psychosocial mediators of
antiretroviral non-adherence in HIV-positive adults with substance use and mental health problems.
This challenging population included 1,889 HIV positive patients on antiretroviral therapy (ARV).
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The purpose of the study was to investigate whether or not non-adherence to ARV could be
explained by difficulty in getting the treatment and/or negative attitudes toward ARV medications.
Difficulty in getting the medications and a poor fit with lifestyle were documented as the two most
significant mediators. Poor fit with lifestyle referred to heavy use of alcohol and narcotics, which
compromised memory, motivation, and social support.
With the advent of Medicaid and Behavioral Managed Care, physicians and mental health
professionals have more aggressively sought ways to increase patient compliance and appropriate
utilization of services. One area of focus studied by Moore-Greene (2000) involved an attempt to
standardize social indicators to enhance medical case management, including compliance. The
result was the development of what the author referred to as “life indicators”, which she loosely
defined as bio-psychosocial problems, with emphasis on environmental situations such as poor
access, and lower SES; these appeared to be moderately correlated with poor compliance and other
negative health measures. She concluded that life indicators could be readily incorporated into a
medical case management model to target noncompliance and inappropriate utilization. More
recent research suggests that doubling co-payments for prescriptions leads to increased use of
emergency department visits (17%) and increased hospital days (10%) for the sentinel conditions of
diabetes, asthma, and gastric acid disorder. (Goldman, et al., 2004).
In addition to financial barriers, patient characteristics such as age and education have also
been studied. Huyser, et al. (1997) examined factors affecting adherence to rehabilitation
interventions for individuals with fibromyalgia. The subjects were followed through a six-week
training program, with questionnaires and physical exams. Although treatment factors revealed a
modest correlation with overall adherence, the best model for predicting adherence suggested that a
subject’s age and education were the strongest influences.
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In a study to evaluate the correlates of compliance with follow-up appointments and the
filling of prescriptions following an emergency room visit, only 45% of more than1300 patients at
an urban hospital could recall being advised to take a medication; of these, 12% reported that they
did not obtain the medication. Of those who indicated that they were given follow-up appointments,
33% said they missed their appointments. Although lack of insurance was an independent correlate,
dissatisfaction with discharge instructions was also identified as a correlate of not filling
prescriptions (Thomas, et al., 1996). Extensive evaluation of the data to assess the underlying
causes of dissatisfaction was not presented.
At the University of Pittsburgh, a recent study to explore the relationships between adherence
with a medication regimen for lowering serum cholesterol and several domains of psychological and
cognitive functioning, researchers found that conscientiousness and IQ were robust predictors of
adherence in hierarchical regression analyses. Depression and anxiety, mental flexibility, and
visuospatial-constructional ability were less robust but still statistically significant correlates of
adherence. (Stilley, et al. 2004)
As healthcare costs continue to rise, Health Insurance Organizations (HMOs, PPOs, etc.)
and other payers (employers) continue efforts to understand human behavior more fully and to
discover ways to influence individuals to reduce health risk factors. Many studies have looked at
specific interventions designed to motivate individuals to practice preventive health care. One such
study was conducted to evaluate the effect of a cash incentive to improve adherence to preventive
health behaviors, specifically to encourage obtaining an annual physical. For 3 consecutive years a
cash incentive of $60 was offered to each individual in a small insured population (1500 people)
who received a complete physical examination within the previous 12 months. On average, 26% of
the eligible participants took advantage of the screening and the $60 incentive. (Manatee County
Government, 2002).
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In a study on compliance, Haynes (1985) also reported that adherence to treatment regimens
was found to be associated positively with the physician’s ability to make the patient feel
understood; there was also a positive association with the patient’s perceived support and ability to
negotiate, feeling as if he or she were collaborating with the physician in the treatment. This adds
credence to the importance of self efficacy in the patient’s general motivation for adherence. In
several studies involving patients with cancer, schizophrenia, and diabetes, the physician-patient
relationship has also been demonstrated as an important factor in therapeutic outcomes (Smith and
Thompson, 1993).
Steiner (1994) examined several aspects of non-compliance to help understand essential
factors that influence this behavior. The results noted many opportunities for misunderstandings
that can and do occur during a healthcare episode. They reported that the essential factors
influencing compliance included patient/provider interaction and thorough drug education, usually
focused on benefits and disadvantages (particularly where side effects were also fully explained).
In another study on understanding communication as a variable, Enguidanos (1997) studied
language as a factor which affects compliance following an emergency room visit. The objective
was to focus on the English language versus the Spanish language as significant variables. Four
additional socioeconomic factors were also compared. They found no correlation between language
and compliance, but they did report that having a primary medical doctor prior to the Emergency
Department visit was positively correlated with follow-up compliance; this was the only significant
socioeconomic variable irrespective of language ability.
In a similar attempt, Thomas, et al. (1996) found that not having made an appointment
before leaving the Emergency Department was an independent correlate of missing follow-up
appointments. In addition, the absence of insurance and dissatisfaction with discharge instructions
were reported as independent correlates of not filling prescriptions. These studies are similar to
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other studies which underscore the value of consistent and reliable information sharing between
providers in order to offer a more cohesive approach to individual care.
Putnam, et al. (1994) found that a commitment-based intervention was effective in
significantly improving patient adherence to medical regimens. Based upon a 10 week antibiotic
regimen, subjects were asked to give verbal and written commitments for adherence and they
completed tasks designed to increase their investments in a medication program. The concept
resembles patient contracting in psychological counseling treatments. During treatment,
unannounced pill counts were conducted and structured tasks were assigned. The authors concluded
that the conscientiousness of the participants was triggered by the verbal and written commitment,
thereby decreasing the likelihood of premature termination of therapy.
Although many studies have analyzed self efficacy, patient education, and provider
communication, other studies which examine a patient’s mental status have also revealed some
interesting outcomes. DiMatteo (2000) evaluated the associations between anxiety and noncompliance and depression and non-compliance, as potentially independent factors. Anxiety proved
to be relatively insignificant as the subjects’ averages were low; however, the relationship between
depression and non-compliance was substantial and significant. They concluded that compared with
non-depressed patients, the odds are 3 times greater that depressed patients will be non-compliant
with medical treatment recommendations. The authors suggested that further research is warranted
among patients who might not be adhering to medical advice in order to explore the value of early
recognition of depression as a risk factor for poor outcomes. In similar work, Delgado (2000)
concluded that the complex nature of noncompliance includes rational and intentional decisions
based on many beliefs, which in turn may be significantly colored by depression. The author
concluded with recommendations to develop strategies directed towards the effective education and
treatment of depression, emphasizing collaboration between the patient and the physician.
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Researchers at the Washington University School of Medicine in St. Louis, Missouri also
found that elderly patients with coronary artery disease who were depressed were significantly less
likely to adhere to their treatment regimens than their non-depressed counterparts (Carney, et al.,
1995).
Non-adherence, Depression, and the Elderly
Nikolaus (1996) structured a study on the elderly to identify problems with medication
compliance during and after hospital stays. They concluded that logistical problems such as
difficulty opening and removing tablets from commercial packages presented serious challenges for
these patients and recommended routine testing of packages during a hospital stay. They also
reported that management of medication should be taught and supervised within the first few days
after discharge from the hospital. Similar results were found by Cramer (1998), in a study to
understand the role of packaging aids and the monitoring of compliance in the elderly.
A data analysis by a large health insurance organization on members over 50 years of age
revealed that age, existing health status, and education seemed to be correlated with adherence to
multiple healthy lifestyle factors. For individuals 50-64 years of age, all three factors appeared to be
statistically significant. For seniors 65 years and older, having a college degree was the only
statistic(?) significant with healthy lifestyles.
Because seniors are the largest single demographic group of healthcare consumers, extensive
research has been invested into ways to improve long-term compliance for chronic diseases. Liu and
Park, (2004) conducted a study to examine whether or not forming detailed implementation plans
for achieving a goal improved older adults’ adherence to a health behavior. They concluded that
continued reinforcement, practice, and training significantly improved the subject’s adoption of
positive health behaviors.
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Franson and Smith (1998) published an article which reviewed the extent of non-compliance
in older adults who take psychotherapeutic agents. Their review found that, in addition to the
patient/provider relationship, belief in the efficacy of the medication, patient education, and the type
of psychotherapy were also influential factors. Although it was not formally assessed, the authors
inferred the importance of a positive therapeutic alliance.
In a separate study of older adults, compliance with adult preventive care guidelines was
conducted, revealing that high knowledge scores, accompanied by recommendations based on
patient history, knowledge of preventive care guidelines, and high self-perceived effectiveness were
independently associated with self-reported preventive care efforts. Female gender also appeared to
be modestly associated with greater attention to preventive care (Ely, et. al., 1998). Recently,
many more studies have been undertaken to focus on senior Americans. A rapidly aging population,
coupled with double digit healthcare inflation has drawn much attention in the political arena. In a
more recent study conducted by Hughes (2004), the author found that older patients may
deliberately choose not to adhere to medication (intentional non-adherence) to avoid adverse effects
of the medication. In addition, when further questioned it became apparent that the patients selected
which medication to skip based upon symptoms; consequently, non-symptomatic conditions such as
hypertension were less likely to be addressed than more painful or symptomatic conditions, such as
migraine or arthritis.

Inappropriate Use of Medications
Misuse of medications is another major cause of morbidity and mortality. Few studies have
examined the frequency of, and factors associated with, discrepancies between what doctors
prescribe and what patients actually take. Bedell, et al. (2000) conducted a 4 month study in private
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practices affiliated with an academic medical center in Boston. A population of 312 patients from
practices of 5 cardiologists and 2 internists were compared by examining medication bottles with
medical records. Although findings could not consistently identify discrepancies across classes of
medications, the types of errors included: patients taking medications that were not recorded,
patients not taking enough of a prescribed medication, and patients taking more medication than
indicated. The authors concluded that discrepancies among recorded and reported medications were
quite common, across all drug classifications. Older age and polypharmacy (complexity of
treatment regimen) were reported as the most significant correlates of discrepancies in general. The
article concluded with an urgent recommendation to address these causes. Disease management
companies understand the dynamics of these issues and those who work with seriously ill
populations employ numerous practical interventions, such as patient diaries, alarm watches, and
pill holders, which reflect recent learnings in this field.
Conditions or treatments which are generally considered non-life threatening or palliative in
nature are less (often)?? (seriously)??? studied. For example, though not generally considered lifethreatening, non adherence with Hormone Replacement Therapy is estimated to be between 70%
and 91% for women from 40 to 60 years of age (Hurley, et al., 1998). The problem resides not so
much in who takes it versus who does not, but who begins and then stops abruptly without telling
her physician. This type of behavior supports susceptibility theories such as the Self-Regulation
Theory and the Health Belief Model, suggesting the perceived severity of the condition and relative
susceptibility to negative consequences is relatively low.

Non-adherence and Asthma
Data from the National Health Interview Survey (1980 – 1990) reported that the ageadjusted prevalence rate of self-reported asthma increased by 38% over this time period.
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Additionally, Taylor found a significant increase in the prevalence of asthma in children younger
than 18 years of age (from 3.2% in 1981 to 4.3% in 1988) (Creer & Levstek, 1997). There are
many thoughts about the cause of this increase, such as air pollution, inner-city congestion, and the
need for better identification and diagnosis. The corresponding physician visits for asthma increased
from 6.5 million to 7.1 million during the same timeframe. What is more alarming, however, is the
sharp increase in deaths from asthma, which rose 46% between 1980 and 1989 (Creer & Levstek,
1997). Given the rapid development of newer and more effective treatments for asthma, the increase
in deaths is particularly distressing and underscores the importance of treatment adherence,
specifically in manageable conditions such as asthma. Non-compliance with prescribed medical
regimens and an inability to use medications properly, especially inhalers, has been identified as
possible causes of increased morbidity and mortality associated with asthma (Legorreta, 1998).
In a study of health beliefs and compliance with asthmatics, Chambers, Markson, Diamond,
Lasch, and Berger (1999) found that patients were more likely to report regular use of inhaled
corticosteroids if they saw themselves as active participants, meaning that they collaborated with
their physician in treatment and they viewed asthma as a serious illness. Their beliefs about the
consequences and their perspective on personal control over the disease supported the concept and
importance of patient education and of shared decision making to achieve better outcomes in the
treatment of asthma. This also lends credibility to the concept of self-efficacy and the constructs of
Social Cognitive Theory as applied to patient adherence.
Non-adherence and Kidney Disease
Much of the literature on treatment compliance has focused on attributions, health beliefs,
and emotions as influencers of adherence. In a separate study on these variables with hemodialysis
patients, Friend, et al. (1998), found that of these three potential factors, attributions appeared to
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play a more significant role than either health beliefs or emotions, though none significantly
predicted both absolute fluid levels and fluid adherence. Health beliefs predicted changes in fluid
adherence, but attributions predicted absolute fluid adherence. Negative emotions showed no
correlation with absolute fluid levels or changes in fluid adherence.

Non-adherence, Heart Disease and Hypertension
A study involving cardiac patients found that physicians ranked hospital recommendations
as one of the most important sources of patient information and one of the most important influences
on patient compliance, stating that patients who were recently hospitalized were much more likely to
follow treatment regimens, post-discharge, than those who had not been hospitalized. The results
did not follow the length of time that patients followed treatment post-discharge nor was further
investigation conducted to evaluate the patient’s interpretation of the significance of hospitalization,
nor whether the hospitalization was the primary influential factor. Nevertheless, the physician’s
perceptions of the patient’s attitudes regarding compliance are recognized as fertile ground for
research. (Feely, J. 1999).
Steiner (1994) conducted a three-part review on patient compliance in an effort to outline the
term compliance. The results focused on the complexity of medical regimens, and emphasized the
fact that it is the patient and physician interaction which seems to determine more heavily the
likelihood of compliance, especially when (?) symptoms are not evident. Similar results were found
by Sung, et al. (1998) in a study of patients with hyperlipidemia. In this asymptomatic condition,
factors that appeared related to poor adherence included gender (females were lower in compliance),
patient/physician communication, complexity of regimen, side-effects, perceived health status, and
comorbidities. Patients who reported previous histories of good compliance were also more likely to
adhere to their treatment regimens. The data did not offer an explanation for the differences in
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gender, although it is worth noting that many medications for hypertension and other heart
conditions are contraindicated in women of child bearing age.
In a study at the University of Southern California, 86% of new antihypertensive drug
therapy patients interrupted or stopped purchasing medication during the first year. Each of the
patients who interrupted therapy used an additional $873 for health care in that 12 month period.
The higher costs were primarily due to increased hospital expenditures (Cramer, 1997). Ischemic
heart disease is one of the major causes of morbidity and mortality in the United States, representing
over 20% of all deaths in 1996 (Sung, et al., 1998). Many of the risk factors for this chronic
condition are well established and preventable, i.e. diets high in cholesterol, hypertension, smoking,
physical inactivity, obesity, depression, and diabetes. Moreover, the Multiple Risk Factor
Intervention Trial (MRFIT, 1998) has documented the fact that persons with combinations of risk
factors such as hypertension, hyperlipidemia, and diabetes are at higher risk for cardiovascular
disease and associated mortality (Chang, et al., 2001). If physicians were able to influence patients
to adopt positive health behavior changes, the necessity for medication could be significantly
reduced, as would unnecessary hospitalizations and physician visits.
One in four adult Americans has high blood pressure and nearly a third do not know they
have the condition. Nearly 15 percent of individuals with hypertension are not on any type of
therapy (special diet or drugs) and 25 percent of those on therapy are not taking adequate
medication nor are they using measures to achieve desired blood pressure goals. Roughly 50% of
hypertensive patients who have experienced a cardiovascular event discontinue cardiovascular
rehabilitation within the first year of the event; between 16% and 50% discontinue medication
within the first year; and greater than 79% relapse and begin to smoke again within the first six
months of an event (Burke and Dunbar-Jacob, 1997). Hypertension is easily detected and usually
controllable. Non-Hispanic blacks (particularly males) and Mexican Americans are more liable to
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suffer from high blood pressure and have a greater mortality rate, than are non-Hispanics. People
with lower educational and income levels also tend to have higher levels of blood pressure. The use
of medication and lifestyle modification (including diet, smoking cessation, and exercise) are wellestablished behavior changes that can help control high blood pressure. Controlled hypertension
reduces the risk of other cardiovascular disease and resulting healthcare utilization. However this is
only true for patients who are cooperative and responsive to treatment, i.e. adherent to treatment
and/or medication. Research has revealed that patients have high adherence if they sustain their
routine for at least 6 months (American Heart Association, 1999).
Meta-analyses indicate that patients with mild-to-moderate hypertension can benefit
significantly from even modest blood pressure reductions. A reduction of 5mm Hg in diastolic
pressure would reduce mortality from stroke by 40% and from coronary heart disease by 14%,
(Rudd, Ahmed, Zachary, Barton, and Bonduelle, 1990). One of the key challenges with
hypertension is to convey the severity of the condition in terms that influence the patient’s attitude
and motivation.

Non-adherence and Communicable Diseases
Numerous studies have linked social support to better medication adherence among illness
groups, but few have examined potential mechanisms for this relationship. Gonzalez, et al. (2004),
in their research on social support, positive states of mind (PSOM), and HIV treatment adherence in
men and women, found that depression and PSOM were highly correlated with better adherence,
whereas higher depression scores related to non-adherence.
It is widely recognized that adherence to antiretroviral therapy is critical to long-term
treatment success, yet rates of adherence to antiretroviral medications are also frequently
subtherapeutic. In a United States study of HIV patients, compliance with a complex treatment
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regimen was assessed to determine modifiable conditions associated with suboptimal adherence,
including how well clinicians predict patient adherence. The findings (Patterson, et. al. 2000)
indicated that a clear and significant relationship between compliance and clinical outcomes was
evident, (i.e. virologic failure and treatment compliance); however, the underlying cause for poor
compliance was not apparent. Moreover, physicians and nurses could predict adherence correctly in
fewer than 50% of the cases. Existing studies on compliance suggest an inverse correlation between
the number of medications that patients take and the degree to which they comply with their
treatment regimens.
Bedell, et al. (2000), studied compliance with complex regimens of HIV patients and also
concluded that dosing is a relevant consideration, with greater compliance typically associated with
fewer doses per day in some subsets of patients. This may offer some explanation about the reasons
that some individuals with complex diagnoses fail to adhere to medication treatment regimens.
However, this behavior pattern is not consistently observed in HIV patients who are generally still
more compliant than average, yet maintain very complex treatment regimens. This may lend
credence to the Health Belief Model, which attributes, to some degree, adherence to the individual’s
perceived threat (HIV is viewed as a very deadly disease) compared with their perceived ability to
manage it (medication is seen as the only hope of slowing disease progression).
A study was conducted by the University of California, San Francisco (UCSF), Center for
AIDS Prevention to learn more about the factors that motivate or deter patients from multi-drug
therapy. Through in-depth interviews the researchers learned that patients who were not on therapy
most often indicated they would be motivated to start treatments if they experienced a decline in
their health status (fear) and/or if they received strong recommendations from their physicians to do
so (Key, 1998). Here again, the patient/physician relationship appears to be critical, although
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perceived loss of freedom (patient denial) and co-morbidities such as depression may also be very
important factors.
Similar research results were reported in a 2004 study by Reynolds, et al., which examined
beliefs about antiretroviral therapy and psychosocial characteristics of HIV-positive persons.
Among a subset of 325 patients reporting current use of medications (nonantiretrovirals) during the
prior month, depression was the strongest correlate of non-adherence. The most common reasons
given for non-adherence to the medications, in descending order, were “simply forgot”, “away from
home”, and “busy”. The authors concluded that personal and situational factors such as depression,
stress, and lower education were associated with less certainty about the potential for treatment
success and with the perceived ability to adhere.
In the March, 2000 issue of Health Psychology, Catz, et al. published their study on patterns,
correlates, and barriers to medication adherence among persons who were prescribed new treatments
for HIV disease. The study included 63 men and 9 women on highly active antiretroviral therapy.
Subjects completed measures of medication adherence, of psychological characteristics, and of
barriers to adherence. After 3 months, nearly 33% of the subjects had missed doses during the
previous 5 days. Depression, side-effect severity, self-efficacy, and social support were the most
significant correlates of poor adherence.
Another study with a homeless population examined the effect of cash incentives to improve
adherence to tuberculosis preventive therapy. An intervention group was compared with “usual
care”, and the results showed a significantly better compliance rate in the group that received the
monetary incentive ($5 biweekly cash) (Tulsky, et al., 2000). Although the results of this kind of
intervention may be intuitive in this unique population, these kinds of studies offer useful
information and lay the foundation for continued research on the domains of non-adherence and the
interventions that show promise.
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Non-adherence and Preventive Care
In addition to researchers, employers have also attempted to understand how and why people
comply with healthy behavior regimens, particularly with respect to preventive care. Weinberg
(1997) reported that eliminating a common barrier, specifically access, played a significant role in
facilitating a higher compliance rate with recommended mammography guidelines. Employees were
offered mammograms at the work-site, resulting in 89.5% of women receiving at least one
mammogram, and 44.6% practicing monthly self-exams. Though not significant, the compliance
rate favored Caucasians and women with a family history of breast cancer, suggesting that the
relevance (perceived threat) of the disease was also a factor. In 1995, Friedman, et al. found that
utilizing the Health Belief Model, analyses of behaviors and intentions to obtain mammograms
suggested two strong predictors of breast cancer screening – physician recommendations and
perceived barriers.
A meta-analysis of studies evaluating the effect of patient education and counseling for
preventive health behaviors conducted in 1997 by Mullen, et al., revealed that education and
counseling conducted by the primary care provider does help patients adopt healthier lifestyles
across many behaviors; however, emphasis was placed upon the types of behaviors changed, and
recognized that addictive behaviors such as smoking and alcohol abuse were more challenging
issues.
In summary, there is significant and relevant literature which indicates the degree of concern
surrounding the issue of non-adherence, including the magnitude of the problem. This problem
contributes substantially to the high costs of healthcare in the United States, not only through poorer
health outcomes, morbidity, and death, but also indirectly in reduced quality of life, disability, and
intangible measures of productivity. A better understanding of the fundamental issues of non-
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adherence as well as their key contributing factors is essential to improving the long term health
status of Americans.

Rationale
The primary point of care in the healthcare delivery system takes place in the physician’s
office. The principal provider/patient interaction represents the initial step in each unique episode of
care. What the physician does within practice is really involved with behavior prescriptions, such as
eating, sleeping, exercise, and medication. However, the physician usually does not target nonadherence and often underestimates it. This may be due to the fact that there are so many possible
factors contributing to non-adherence that it is difficult to know which factors are operating for any
given patient at a given point in time. (Claydon, Efron and Woods, 1997). For example, in a metaanalysis conducted by Lisper, Isacson, Sjoden, and Bingefors (1997), the effects of patient education
revealed that behavior-oriented instructions concerning the use of drugs (based on the patient’s own
daily routines) were more likely associated with better compliance because the information was
personal and specific. Without delineating possible reasons for compliance, however, therapy
becomes less focused and may be only partially effective, if effective at all. If the constraints placed
upon a physician’s time within our fractured healthcare system are included, the ability to identify
prospectively or to react to patient’s behavior is even further compromised. To the extent that the
patient does not comply with his/her prescribed regimen, numerous, additional outpatient visits
and/or hospitalizations may be necessary, compromising the quality of life for the patient, while
adding to increased financial burden for the patient and healthcare system alike. The result is
significant and additional, but often avoidable, costs to society, to families, and to the individual’s
quality of life. As previously stated, non-adherence is a serious problem with potentially lethal
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consequences. Non-adherent patients may allow a disease to progress, and may require more
invasive procedures, and more aggressive medications. When a physician understands the adherence
issues that may affect a specific patient’s likelihood of complying with the treatment regimen, he/she
is better prepared to offer the appropriate support at the beginning of the treatment process in order
to facilitate better outcomes. Approaches to improve adherence, such as those outlined by Creer
(1996) and Chambers et al. (1999), suggest that by identifying patient’s issues, by altering treatment
regimens and by applying behavioral techniques, the physician is able to influence outcomes
positively.
In the absence of reliable and practical methods to predict which patients will not adhere to
their recommended treatments, physicians and other healthcare providers are left with their own
judgments. Frequently these judgments are based upon experience, either with those particular
patients, or in general over time with multiple patients and conditions. This approach leaves both
the provider and patient vulnerable to the consequences of non-adherence. An instrument that
reliably predicts patients’ health behavior problems would provide a profile of factors contributing
to non-adherence. A tool of this nature would be invaluable in aiding the physician in the selection
and implementation of appropriate interventions, which could ultimately lead to lower healthcare
costs, higher quality of life, and a lighter burden of illness for all those who share the costs of poor
health outcomes.

Purpose of the Study
The purpose of this study is to develop and validate a self-report screening instrument with
valid and reliable psychometric properties so that it may be useful to identify those prospective
patients with chronic disease who are less likely to comply with their medical treatment regimens.
The framework for this instrument is the Health Adherence Behavior Inventory (HABIT) developed
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by DiTomasso in 1997. The original questionnaire was initially used by DiTomasso and colleagues
to assess medical patients in an urban medical center. Patients who failed to progress as well as
anticipated in their treatments, and who were less compliant with their physicians’ instructions,
appeared to exhibit similarly poor lifestyle habits. The need to address these issues earlier in the
treatment process inspired the use of screening questions to elicit relevant information for the
primary care and mental healthcare providers. This information proved useful in the early
identification of problematic issues surrounding the patients’ behavior and ultimate health outcomes.
The questions evolved from observations made by the healthcare team regarding patients who were
observed to be or who were suspected to be non-compliant. Specifically, the original items were
intended to provide a brief but useful screening for positive health behaviors that were consistent
with adherence and with better health outcomes. Hypotheses concerning the utility of this
instrument suggested that it would ultimately be brief, reliable, and be able to differentiate the noncompliant patient from the compliant patient. This led to further refinement of the items and a
consideration for more rigorous evaluation and empirical study. The present study was proposed to
examine the psychometric properties of the HABIT, specifically to assess the construct validity, the
internal consistency, and the factor structure of the questionnaire. Construct validity was assessed
by comparing the HABIT with a well documented and validated Health Risk Assessment by
Lifestyle Directions, Inc. For the purposes of this study, medical treatment regimen was confined to
treatment protocols involving medication, exercise, and diet, with emphasis on medication. Chronic
disease was limited to specific diagnoses indicative of hypertension.
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Research Question/Hypotheses
The research question for this study was based on the idea that it is possible to predict nonadherence in a medical patient population. The hypothesis for this study presumed that individuals
who are routinely non-adherent with medical treatment regimens tend to possess similar state/trait
characteristics so that they can be identified in a practical and efficient manner (i.e. Questionnaire)
to facilitate interventions by a professional healthcare provider.
The research hypotheses were as follows:
1. The HABIT would possess content validity as established by an expert panel of
healthcare professionals.
2. The HABIT would possess construct validity as demonstrated through factor analysis.
3. The HABIT would demonstrate internal consistency reliability.
4. People who were rated as less likely to comply with a prescribed treatment regimen
would score significantly differently on the HABIT from those who were rated as more likely to
comply with similar treatment regimens. The degree of compliance would be measured by the
following possession ratio calculation:
Days Fill
Ratio =

# of days in the previous 6-12 months for which the subject had recorded filled Rx
# of days in the previous 6-12 months for which the subject had a recorded Rx

The closer this ratio to “1”, the greater the degree of compliance with medication (a ratio of “1”
would indicate that the subject had sufficient medication for an entire prescribed period). It was
anticipated that the results of this study would reflect a positive correlation between the scores on the
Health Adherence Behavior Inventory (HABIT) and the Days Fill Ratio/Possession Rate.
5. There would be a negative correlation between the number of self-reported, positive
health behaviors on the HABIT and blood pressure level.
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CHAPTER 2
METHOLODOGY
Subjects
The subjects for this study were randomly selected from a population of eligible volunteers
who presented at one of three pharmacies to receive a prescription for the treatment of hypertension.
Subjects could be male or female and between the ages of 18 and 65.
A total of 300 subjects with completed surveys and screenings were required to complete this
study as designed. Only subjects who had been diagnosed with hypertension within at least the prior
6 months and were currently being prescribed medication to treat hypertension were accepted into
the study. The subjects were queried to confirm the fact that they consistently filled their
prescriptions with the same pharmacy.
Subjects may have had other concomitant conditions, provided these conditions did not
preclude the subject from voluntary participation or render the subject housebound or bedridden.
Participation was voluntary and subjects had to be willing to provide consent in writing by returning
a signed consent form. Subjects were free to withdraw from the study at any time.
Participants were also required to understand and respond in English, utilizing, at a minimum,
language ability at an 8th grade reading level.
Interested volunteers who were participating in other studies, including, but not limited to,
clinical research trials, behavior modification studies, health surveys, or disease management
studies, were not accepted into the study. Patients who were institutionalized or hospitalized were
also excluded from the study.
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Design
This study employed a correlational research design to assess the psychometric properties of
the Health Adherence Behavior Inventory (HABIT).

Description of Instruments and Measures
Health Adherence Behavior Inventory (HABIT) The Health Adherence Behavior
Inventory, (DiTomasso, 1997), is a 50 item, dichotomous questionnaire, developed by DiTomasso
for use in primary care settings. (see Appendix B) The original questions were designed and
delivered by healthcare providers in an ambulatory setting in an effort to uncover useful information
to support an individual patient’s treatment progress. The HABIT includes items that describe
ordinary health-related behaviors, “habits”, such as following physician’s advice, getting
prescriptions filled as soon as they are received, limiting intake of fatty foods, avoiding smoking, etc.
The respondents are asked if the described behavior is generally true or not true of their own
behavior. Responses correspond with a numerical value: (True = 1, False = 0). A total score is
then calculated by adding the response values from all completed items. Most of the items are
presented in the affirmative, such as “I limit the amount of sugar I consume”, or “I eat enough fruits
and vegetables”. Three of the 50 items are framed in the negative, meaning that the item describes a
negative behavior or attitude, such as “People tell me I am a couch potato”. These items are reverse
scored. It was anticipated that a higher score on the HABIT (indicating frequent practice of positive
health behaviors) would correlate to a lower score on the Health Risk Assessment (reflecting lower
risk of developing a disease).
Health Risk Assessment. (HRA) The Lifestyle Directions (LDI) HRA is an established
health risk assessment that has been widely used for more than 20 years to measure risk of disease.
The questionnaire has been well studied and correlates highly with direct medical costs and
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utilization claims data. (see Appendix C) The HRA includes 113 items that solicit health-related
history, behaviors and attitudes, as well as biometric screening values (to be entered by a clinician
upon completion of blood screening and biometric measures). The number of questions and
categories are broken down (?) as follows: (demographics = 3), (medical history = 38), (physical
health = 9), (dietary habits = 10), (lab values = 7), (screening history = 3), (personal habits = 11),
(attitudes on health = 6), (medications/drug use = 15), (exercise attitude = 1), (women only health =
7), and (men only health = 3). The HRA is a validated instrument with a proprietary algorithm
(owned by Lifestyle Directions, Inc.) which is applied to all responses. The analysis of responses
yields a percentile score of “Overall Health Risk”. The percentiles range from minimal risk (0% 25%), to moderate risk (26% - 50%), to major risk (51% - 75%), to severe risk (76% - 100%). It
was anticipated that a lower Overall Health Risk score (percentile %) would correlate with a higher
numerical score on the HABIT.
The LifeStyle Directions, Inc. HRA is one of the oldest and most frequently utilized HRAs on
the market. A substantial study comparing HRAs was published in 1987 by Smith, et al. in the
American Journal of Public Health, in which 41 HRAs were compared in terms of their validity in
predicting risk of future coronary heart disease. The study classified the HRAs into five categories,
depending on their science-base and method of scoring. The morbidity and mortality based HRAs
required computer scoring. The others could be scored by hand. The correlation of true risk of
cardiac death and HRA-based estimates of risk of cardiac death ranged from 0.145 to 0.800, with
0.000 being worthless, and 1.000 being perfect. The two morbidity- (illness) based HRAs had
correlation scores of 0.800 and 0.763, respectively. LDI-HRA is a morbidity-based system. Thus,
in a crowded HRA marketplace, the morbidity-based HRAs distinguished themselves in terms of
validity. The LDI-HRA, the first of the morbidity-based HRAs, has also distinguished itself by its
documented efficacy and its sensibly balanced approach to the needs of participants, physicians, and

Non-Adherence

34

payers. The HRA includes age specific and gender specific questions from which the response data
generates an individualized Personal Health and Vitality Guide. Complementary tools include
Health Risk Summary Sheet, Report Card and aggregate Corporate Vitality Reports for the group.
These components are serial, both for the individual and the group, and are designed to track
changes over time. Subsequent response data is measured, compared and linked with the prior data.
Changes are shown in percentile risk scores and in the individualized paragraphs. Over 15 essential
categories such as biometrics, screenings, lifestyle health habits, etc. are analyzed to create
participants’ risk profiles based upon diet, exercise, stress and other factors that inhibit current
physical and mental activities and increase risk of future illnesses. It is important to note that
although sequential administrations are useful measures of individual change, baseline
administrations (or once only analyses) also offer meaningful opportunities to assess individual and
group risk factors. The information can also be very valuable to respondents who are unaware of
the severity of their current health status.

Biometrics: Blood Pressure, Glucose, and Lipids Biometric tests are important measures of
health status and are routinely performed by licensed healthcare practitioners. For this study, a
licensed Pharmacist conducted the assessments in the pharmacies during the interview and testing
process. These lab values/readings are important components of the overall health risk assessment
algorithm.
Blood Pressure was measured using the Auscultatory Method. A mercury-gravity reader
and blood compression cuff was used with a stethoscope over the brachial artery to read systolic and
diastolic blood pressure. Current JNC VII and American Diabetes Association (ADA) blood
pressure goals are <140/90 mm Hg or <130/80 mm Hg for patients with diabetes or chronic kidney
disease.
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Hypertension, most commonly referred to as high blood pressure, is a major determinant of
cardiovascular disease. The relationship between blood pressure and risk of cardiovascular events is
continuous, consistent, and independent of other risk factors. The Seventh Report of the Joint
National Committee on the Prevention, Detection, Evaluation and Treatment of High Blood
Pressure (current JNC VII) guidelines report that for individuals 40-70 years of age, each increment
of 20 mm Hg in SBP (Systolic Blood Pressure) or 10 mm Hg in DBP (Diastolic Blood Pressure)
doubles the risk of CVD (Cardiovascular Disease) across the entire blood pressure range from
115/75 to 185/115mm Hg. In persons older than 50 years, Systolic Blood Pressure (SBP) >140
mm Hg is a much more important CVD risk factor than Diastolic Blood Pressure (DBP).
Glucose and lipid values are obtained directly from a blood sample. Cholestek kits, which
were used in this study, are among the most widely used population based testing products currently
on the market. Blood samples are collected from the subject’s fingertip, requiring only a small drop
of blood to calculate glucose, LDL, HDL, and Triglycerides. Normal glucose concentration in the
blood is 80 to 120 mg/dl. Normal/desirable total cholesterol value is <200 mg/dL.
Normal/desirable LDL value is <130 mg/dL. Normal/desirable HDL value is >35 mg/dL.
Normal/desirable triglyceride value is <150 mg/dL. These measures were recorded by the
Pharmacist who conducted the screenings and were communicated privately to the subjects for
sharing with their doctors.
Weight and Height Weight and height measures are variables assessed for inclusion in the
health risk assessment, (Physical Health Section of the HRA, items 2 and 3). These measures are
utilized in the Lifestyle Directions (LDI) algorithm to assess overall risk. Individuals who are 20%
to 30% over average weight for their age, sex, and height are considered obese. This information is
desirable but not essential for accurate assessment of risk.
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Rating of adherence pharmacy record By agreeing to participate in this study, each subject
provided consent for his/her pharmacy profile/history to be examined and documented within the
parameters specified in the consent form. This entailed a chart review of the subject’s pharmacy
record to determine the prescriptions indicated for the control of hypertension that the subject had
received within the previous 6 to 12 months. Because there is more than one class of drugs used for
this purpose, it was necessary for the pharmacist to identify the universe of appropriate medications
for examination. A list of the NDC codes for those medications with a documented, FDA approved
indication for lowering blood pressure was compiled and used by the pharmacist who was
conducting the chart reviews. The pharmacist asked the subjects if they were currently taking
medications for blood pressure control (antihypertensive), and if so, which medications. The
subjects were also asked to indicate the time when they were told initially by their physicians that
they had high blood pressure (hypertension) as well as the time when they were first prescribed
medications to control their blood pressure. The pharmacist recorded the subjects’ responses on the
spreadsheet and examined the patients’ medication refill histories to determine the fulfillment ratio
for their hypertension medications. The ratio was calculated by dividing the number of days
dispensed (# of pills ÷ dosage) since first prescription by the number of days since first prescription.
For purposes of this study, a ratio = 1 was interpreted as 100% adherence. Any ratio of <1 was
interpreted as less than fully compliant. It was anticipated that the lower the fulfillment ratio, the
higher the relative Blood Pressure of the subjects would be.

Procedure

Assembly of packets
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Measures and forms were assembled into identical packets, consisting of the following
materials necessary for each subject: (1) Informed Consent; (2) Health Adherence Behavior
Inventory (HABIT); (3) Health Risk Assessment (HRA); (4) Subject Ticket for incentive drawing;
and (5) Investigator assistant checklist of all necessary measures and dates of completion. (see
Appendices A, B, C, and E) The checklist was provided for the pharmacist’s benefit so that he
and/or his assistants could quickly review each subject’s packet for completion prior to data entry.
Each packet, including all papers within the packet, was sequentially numbered to ensure that each
respondent’s data was confidential, yet were accurately captured and recorded in a consistent and
ethical manner. A total of 300 packets were prepared.

Questionnaire Development
Through a comprehensive collection and review of relevant literature, the authors of the
HABIT identified and selected the appropriate domains which were to be used. Items were chosen
to represent the universe of non-adherent risk behaviors affecting health outcomes. The investigator
solicited independent expert review to ensure that the domains adequately represented the universe
of non-adherence. The expert panel was composed of two psychologists and two physicians,
including an internist and a family physician. The final item pool of all potentially relevant and
appropriate questions were refined and developed. (Appendix B) Experts were asked to place items
in clear and understandable domains, (e.g., verbal monitoring) retaining only those items upon
which 100% agreement was achieved. The questionnaire was developed and the items were
randomly ordered.

Site Selection
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A suitable population in which pharmacy claims data was accessible (such as a pharmacy)
was identified, and three pharmacies were selected to screen and assess subjects. It was essential that
the selected sites offered private screening areas where subjects could be interviewed and tested. It
was also important that the subjects received all of their hypertension medications from the same
pharmacy. The three pharmacies were owned and operated by a licensed Pharmacist in the State of
Georgia, with additional licensure to perform cholesterol and glucose screening tests. Approval and
cooperation by the identified organization was obtained to solicit subjects for participation in this
study prior to initiating the study. The pharmacy was responsible for soliciting patients for
participation, explaining the informed consent, performing the appropriate blood screening, weight
and height measurements, ensuring that all questionnaires were completed, and examining and
recording the subjects’ prescription refill records.
The investigator developed a poster (Appendix D) to solicit participation and enrollment, as
well as a Question and Answer Instruction Sheet (Appendix E) to which the pharmacist might refer
when answering questions from interested patients. A consent form (Appendix A) was also
developed to ensure informed consent was documented. A health risk assessment was selected for
inclusion in the data (Appendix C). To facilitate participation, the investigator selected and offered
an incentive to be offered to study participants.
IRB approval from Philadelphia College of Osteopathic Medicine was obtained.

Subject Recruitment
Two weeks prior to beginning the study, the principal investigator met with the pharmacist
and his assistant in order to train them on the administration of the surveys; this was done to ensure
complete understanding of the procedure. At that time, 300 packets which were prepared by the
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investigator were provided to the Pharmacist (100 packets per pharmacy) ; a recruitment poster
(Appendix D) was placed in each pharmacy indicating the nature, requirements, and timing of the
study, along with a description of the incentive to participate. During this two week period, the
pharmacist was instructed to use the Question and Answer Instruction Sheet (Appendix E) to
respond to questions from prospective subjects. This form helped to ensure a consistent recruitment
process by enabling the pharmacist and assistants to answer similar questions in the same manner.
Within 2 weeks of placing the posters in the pharmacies, the Pharmacist advised the Investigator that
pharmacy customers asked numerous questions, indicating that the posters and communication
about the study were achieving the objective of generating interest about the study.
Once the study officially began, the potential subjects were randomly recruited (every 3 rd
eligible patient) from all patients who presented at the pharmacy with a prescription for hypertension
over a 5 month period.(LASTING OVER A 5 MONTH PERIOD? HAD BEEN GETTING THE
PRESCRIPTION FOR 5 MONTHS?) When a patient presented at one of the three pharmacies with
an appropriate prescription, the individual was asked by the pharmacist or assistant if he/she would
be interested in participating in the study. If the patient responded positively, the
pharmacist/assistant probed the patient with additional questions to determine the individual’s
appropriateness for inclusion in the study. Interviews and tests were conducted in a private room
within the pharmacy.

Subject Testing
After the pharmacist/assistant was assured that the subject met the study inclusion criteria,
the subject received one of the packets with an Informed Consent Form explaining the study, a
Health Risk Assessment, a Health Adherence Behavior Inventory (HABIT), a ticket for the
incentive drawing, and biometric screenings (lab work). Each subject who agreed to participate in
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the study was required to complete the HABIT and the Health Risk Assessment (HRA)
questionnaire after signing the consent form. The investigator at the pharmacy site was responsible
for ensuring that the questionnaires were answered completely. All data was gathered by the
pharmacist and an assistant who was blinded to the study. Following completion of the
questionnaires, the subject submitted to a full lipid panel and blood pressure screening, as well as
height and weight measurement. The cholesterol test involved a tiny prick of the subject’s finger to
obtain a small blood sample. The sample was analyzed for cholesterol, glucose, and triglycerides.
All blood testing, weight, and blood pressure measures were performed by a licensed healthcare
provider at the pharmacy (satisfactory licensure documentation was provided to the principal
investigator prior to initiation of the study). The healthcare provider shared results of the screening
with the subject and offered general interpretation of the results. Subjects were provided with a
hardcopy of their lab values and encouraged to share these results with their primary care
physicians. Specific questions concerning lab results were referred to the subjects’ physicians.
Although all subjects were encouraged to share the results of their screening with their physicians,
any subject whose results indicated that an urgent referral to a physician was warranted, would have
been asked permission for the pharmacist to communicate directly with the subject’s physician by
telephone to communicate their results. No results were obtained which warranted such actions.
Completion both of questionnaires and lab work took approximately 30 minutes for each subject.
Upon the receipt of completed materials, the pharmacist / assistant reviewed the responses
for completeness, segregating those that were incomplete from completed questionnaires. When the
pharmacist or assistant was satisfied that all items were complete, the subject was thanked for his or
her cooperation and given a copy of the lab results.

Data Entry and Reporting
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All data from completed questionnaires and lab work was entered into a spreadsheet
database by an assistant blinded to the study. The HABIT and the Health Risk Assessment (HRA)
were pre-numbered to correspond with each other (one unique identifier per questionnaire per
subject which was administered at the same time). Responses from the HABIT and the HRA were
entered by the pharmacy investigator assistant into a spreadsheet template which was provided to the
pharmacy study site prior to the beginning of the study. Upon completion of the study, the
pharmacist investigator assistant made copies of all questionnaires as well as copies of the completed
spreadsheet containing all responses. One copy of all materials remained with the pharmacy until
completion of the study, at which time they were to be destroyed. Each subject who agreed to
participate in the study was required to complete both the HABIT questionnaire and the Health Risk
Assessment after signing the consent form.
Completed HRA questionnaires were bulk shipped from the Pharmacy to LDI (Lifestyle
Directions, Inc, Pittsburgh, PA.) for analysis. The vendor processed each HRA and provided the
pharmacy assistant with individual HRA (%) scores for each participant. The subject was identified
only by subject number. The HRA percentile (%) risk scores given by LDI to the pharmacy
assistant were added to the spreadsheet database. LDI also generated individual reports for the study
participants. This report, “the Personal Health and Vitality Guide”, provided a customized health
status report for each subject based upon his or her responses to the HRA. The health status reports
were sealed in confidential envelopes and bulk shipped to the pharmacy for confidential distribution
by the pharmacist during the patient’s next visit to the pharmacy. The envelopes containing the
personalized health status reports were opened only by the study participant. No identifiable
personal information from these questionnaires or reports was shared with the pharmacist or his
staff. This completed all data collection for this study.
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The completed spreadsheet database was provided to the study investigator for final analysis.
Responses from both questionnaires were compared with each other and with biometric measures of
hypertension, cholesterol, glucose, and weight, as well as with the pharmacy records of refill for the
identified prescription.

Statistical Analysis
Data for this psychometric study were collected and entered into a database (SPSS, Version
12.0). Descriptive statistics were examined. All data was analyzed, including frequency
distribution, mean, median, standard deviation, and standard error. A Principal components
varimax rotated factor analysis, and Cronbach’s coefficient alpha reliability analysis, including
corrected item total score correlation, correlation of scores on instrument, and various psychometric
parameters were calculated.
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CHAPTER 3
RESULTS
This study was conducted over the 5 month period, from January 1, 2004 through May 30th,
2004. A total of 93 subjects completed all requisite questionnaires and biometric screenings. All
subjects were randomly selected from a population of hypertensive patients who presented with an
antihypertensive prescription to be filled at one of 3 pharmacies in the metro Atlanta, Georgia area.
Each subject was currently diagnosed with hypertension and fulfilled the study inclusion criteria of
having an existing prescription for antihypertensive medication for a minimum of 6 months prior to
entering the study. In all, 89 (95.6%) of the subjects had been diagnosed with hypertension for
more than 12 months and 4 subjects had been diagnosed with hypertension for between 6 and 12
months. English was the first language of each subject and all subjects were able to read at a
minimum 8th grade reading level, in accordance with study inclusion criteria. Participation was
voluntary, and a signed, informed consent was obtained from each subject. Subjects could remove
themselves from the study at any time. Also, in accordance with exclusion criteria, none of the
subjects who completed the study was institutionalized, hospitalized, or currently participating in
any other studies or disease management programs.
Data collected for this study were entered into the statistical software SPSS (Statistical
Program for the Social Sciences, version 12.0). The database was doubled keyed to ensure accuracy
and statistics were computed for all variables. The following tables and discussion represent the
final results and include the descriptive statistics and relevant factor analyses which address the
variables of interest and hypotheses of this study.
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Descriptive Statistics
Of the 93 subjects who volunteered to participate in this study, 17 subjects were males
(18.3%) and 76 subjects were females (81.7%). A total of 73 (78.5%) of the subjects were
Caucasian, 12 (12.9%) were African-American, and 8 (8.6%) were classified as “Other”. The
average age of this population was 59.5 years. The majority of subjects, 62 (66.6%), had completed
at least a high school education and within this group 28 (30.1%) also completed some level of
college or beyond. Of those who reported marital status, there were 20 (21.5%) married individuals
in the study, 18 (19.4%) divorced subjects, 22 (23.7%) single subjects, and 29 (31.2%)
widows/widowers. Three of the subjects (3.2%) were working on a full-time, permanent basis. The
majority of subjects (58.1%) had previously retired and the remaining (38.79%) participants were
otherwise employed or disabled. All 93 subjects were insured with both medical and
pharmaceutical health benefits. Of these, 48 (51.6%) had a benefit that required less than a $30 copay to fill a prescription; 36 (38.7%) had a co-pay benefit requiring less than a $20 co-pay per
prescription refill. The remaining 9 subjects had no co-pay for prescription drugs.

Responses to the HABIT
All 93 subjects (100%) in this study fully completed the Health Behavior Inventory
(HABIT), as well as biometric screenings. The HABIT consists of 50 items that describe ordinary
health behavior “habits”, such as getting annual physical exams, wearing sunscreen, exercising and
using seatbelts. Subjects responded “true” if the described behavior generally matched their own
behavior and “false” if they disagreed that the described behavior was similar to their own. Table 1
represents the frequency distribution of all variables (50 items) included on the HABIT. Three
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items identified are reverse scored, meaning that for a particular behavior, a positive response is
“false”. These statements/behaviors include “People tell me I am a Couch Potato”; I do not take
prescribed medicines as directed”; and “I eat meals while doing other things.” If a subject agreed
with these statements and responded “true”, the behavior would not be considered a “positive health
behavior”. Rather, this would be considered a “negative health behavior”, and analyzed
accordingly.
All items are presented in descending order of positively endorsed response. From this data
it is clear that nearly all (96.8%) of the subjects reported that they followed their physicians’ advice.
Specifically, they reported that they tended to keep their physician appointments, were punctual,
obtained ordered medical tests, and filled their prescriptions promptly. Items less frequently
endorsed included behaviors related to exercise, such as taking stairs over elevators/escalators
(25.8%); practicing relaxation or meditation exercises (32.3%); lifting weights (10.8%); and
jogging (3.2%). This may be related to the relatively older average age of the study group (59.5
years), which implications are discussed later in more detail.

Biometric Results
Biometric screenings were conducted by a licensed healthcare practitioner for each subject,
including blood pressure, total blood cholesterol, high-density lipoproteins (HDL), low-density
lipoproteins (LDL), triglycerides, and glucose (random or fasting). These values were immediately
communicated to the subject by the practitioner. There were 10 subjects in whom the systolic blood
pressure was above 160 and/or the diastolic blood pressure was above 90; these subjects were
queried thoroughly about their “normal” blood pressure readings, their medications, and the
frequency of their physician visits. Similarly, in 36 subjects whose total blood cholesterol measures
exceeded 200, and/or LDL values were obtained higher than 170, participants were asked additional
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questions to assess urgent risk. This additional assessment involved questions related to diet (in
particular, immediately prior to the screening to assess accuracy of reading), as well as to existing
medication regimen, and to the patient’s last physician encounter. If, in the pharmacist’s
professional opinion, the lab results warranted immediate follow-up for the patient, the pharmacist
would have asked the patient for permission to speak with his/her physician. However, based upon
these subjects’ responses, it was determined that none of the lab values obtained by the healthcare
provider were considered to present an immediate danger to the subjects; therefore, no call from the
pharmacist to the subject’s physician was warranted. However all subjects were strongly
encouraged to share their lab results with their primary care physicians for follow-up.
Tables 2 and 3 provide the Systolic and Diastolic blood pressure values, frequency
distributions, and cumulative percentages for all subjects tested. The Systolic Blood Pressure was
found to be significantly negatively correlated to the HABIT , (-.177*), i.e., the lower the systolic
blood pressure the higher the HABIT score.
The additional biometric measures referenced in Table 4 were not specific to the study
hypotheses. Only hypertension, (blood pressure ratios), were metrics of interest for this adherence
study. However, the lab values for cholesterol, triglycerides, and glucose were important metrics for
calculating the subject’s overall health risk and were desirable for more accurate processing of the
Health Risk Assessment. Table 4 provides the minimum, maximum, mean, and standard deviation
for all biometric measures.
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Table 1
Health Adherence Behavior Inventory, Frequency Distribution
Behavior
Keep doctor’s appointments I make
Arrive on time for physician appointments
Obtain tests when ordered by a physician
Get medication prescriptions from physician filled promptly
Take a logical approach to problem solving
Take prescribed medications for recommended period
Follow advice of physicians
Follow doctor’s advice on health matters
Wear seat belts in cars
Take all medications as directed by doctor
Get routine physical exams
Sit in non-smoking public places
Avoid excessive use of alcohol
Able to keep a realistic view of stresses
Do not chew tobacco
Successfully cope with most stresses
Routinely examine skin for unusual markings
Limit amount of fat in diet
Try to eat low cholesterol foods
Avoid cigarette smoke
Limit amount of caffeine consumed
Limit salt intake
Avoid people who smoke
Eat enough fruits and vegetables
Examine breasts or testicles for lumps
Limit amount of sugar in diet
Try to sleep at least 8 hours each night
Get enough emotional support if stressed
Usually eat 3 meals a day
Drink low fat or skimmed milk
Watch calories carefully
Go to bed at a regular time each night
Get enough rest each night
Test smoke alarms regularly
Ask friends not to smoke in my presence
Avoid napping during the day
Am physically active
Avoid fast food restaurants
Weigh myself on a regular basis
Avoid snacking between meals
Exercise on a regular basis
Prefer to walk rather than drive if possible
Wear sun screen on sunny days
Eat meals while doing other things
Practice formal relaxation or meditation exercises
Take stairs over elevator/escalator
Do not take prescribed medicines as instructed
Lift weights
Am told by people that I am a “couch potato”

Percentage with positive response
98.9%
98.9%
96.8%
96.8%
94.6%
94.6%
93.5%
93.5%
92.5%
92.5%
92.5%
90.3%
89.2%
89.2%
88.2%
88.2%
83.9%
83.9%
83.9%
82.8%
82.8%
82.8%
81.7%
79.6%
79.6%
78.5%
76.3%
76.3%
73.1%
72.0%
71.0%
69.9%
69.9%
68.8%
66.7%
64.5%
62.4%
60.2%
60.2%
53.8%
50.5%
47.3%
35.5%
34.4%
32.3%
25.8%
14.0%
10.8%
9.7%
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Jog or run

3.2%

Table 2
Systolic Blood Pressure Values, Frequency Distributions, and Cumulative Percentages
Systolic Blood
Pressure
108
110
118
120
122
124
126
128
130
132
134
136
138
140
142
148
150
152
154
158
160
162
164
168
170
172
185
189

Frequency

Percentage

2
2
6
2
5
2
1
3
6
7
1
2
9
9
4
4
4
3
2
5
2
2
2
2
3
1
1
1

2.1%
2.1%
6.5%
2.1%
5.4%
2.1%
1.1%
3.3%
6.5%
7.5%
1.1%
2.1%
9.7%
9.7%
4.3%
4.3%
4.3%
3.3%
2.1%
5.4%
2.1%
2.1%
2.1%
2.1%
3.3%
1.1%
1.1%
1.1%

Cumulative Percent
2.1%
4.2%
10.7%
12.8%
18.2%
20.3%
21.4%
24.7%
31.2%
38.7%
39.8%
41.9%
51.6%
61.3%
65.6%
69.9%
74.2%
77.5%
79.6%
85.0%
87.1%
89.2%
91.3%
93.4%
96.7%
97.8%
98.9%
100.0%
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Table 3
Diastolic Blood Pressure Values, Frequency Distributions, and Cumulative Percentages
Diastolic Blood
Pressure
50
60
62
64
68
70
72
74
75
76
78
80
82
84
86
88
90
94
96
100

Frequency

Percentage

2
2
2
3
2
4
9
5
3
4
7
16
11
4
4
5
4
2
2
2

2.2%
2.2%
2.2%
3.2%
2.2%
4.3%
9.7%
5.3%
3.2%
4.3%
7.6%
17.1%
11.7%
4.3%
4.3%
5.3%
4.3%
2.2%
2.2%
2.2%

Cumulative Percent
2.2%
4.4%
6.6%
9.8%
12.0%
16.3%
26.0%
31.3%
34.5%
38.8%
46.4%
63.5%
75.2%
79.5%
83.8%
89.1%
93.4%
95.6%
97.8%
100.0%

Table 4
Biometric measures of Blood Pressure, Cholesterol, Triglycerides and Glucose, Minimum,
Maximum, Mean and Standard Deviation
Measure
Systolic BP
Diastolic BP
Total Cholesterol
HDL
LDL
Triglycerides
Glucose

Minimum

Maximum

Mean

108
50
109
20
31
30
64

189
100
460
91
209
650
284

138.2
78.8
195.9
49.6
100.8
224.8
130.0

Responses to the Health Risk Assessment (HRA)

Standard
Deviation
21.2
8.6
47.8
15.4
36.1
101.5
44.8
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As previously mentioned, the validated Health Risk Assessment by Lifestyle Directions, Inc.
(LDI) was utilized in this study to establish construct validity for the HABIT questionnaire.
Individuals who are at greater risk for disease score higher on the HRA than low risk respondents.
This is reflected in an “Overall Health Risk” percentile score. The questionnaire includes 113
items, including a comprehensive medical history, dietary habits, personal habits, laboratory values,
medication usage, and attitudes on health. The overall “health risk” score is calculated using the
Lifestyle Directions proprietary algorithm, which provides a relative measure of the respondent’s
likelihood of developing or exacerbating serious health conditions and compromising quality of life.
A total of 89 subjects (95.7%) completed all items on the HRA. A few individuals did not respond
to all items. The items most frequently missed included waist and hip measurements, attitudes on
exercise, and attitudes towards health in general. These missing data do not compromise the
integrity of the overall health risk score. The algorithm is designed to account for these missing
responses.
Table 5 provides the frequency distribution of all subjects’ responses to the medical history
portion of the HRA. In this section subjects are asked if they or anyone in their immediate families
(parents or siblings) has/had the specified diseases or conditions, which may predispose the
individual to develop similar symptom(s) or condition(s). Consistent with national averages, the
most prevalent conditions included various forms of heart disease, diabetes, and musculoskeletal
disorders. This is particularly noticeable in a population such as this in which the average age was
59.5 years. Over 33% (31) of the subjects also reported depression, for themselves and/or in their
immediate families, including 24 subjects (25.8%) who indicated that they were depressed
themselves. Data is presented in descending order of frequency of overall prevalence within
families. Although hypertension is not specifically referenced in the Health Risk Assessment as an
independent diagnosis, the association between hypertension and other conditions such as
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hyperlipidemia, heart disease and stroke is well established. Thus the prevalence of these conditions
would not be unexpected in a population which was designed to include subjects with a diagnosis of
hypertension.
Table 6 provides, in descending order, the frequency distribution of all subjects’ responses to
the HRA questions related to dietary habits. Subjects were asked to report how many servings of the
listed foods they ate in a typical day; the possibilities ranged from 1 to 5 servings. Greater
consumption of fruits, vegetables and fiber, combined with lesser consumption of fats, oil, salt and
sweets, contributes to a reduced risk for serious disease. A minimum of 2 servings per day per
category is considered significant in the HRA algorithm.

Non-Adherence

Table 5 Health Risk Assessment (HRA)
Medical History, Frequency Distributions, and Percentages
Disease
Heart Attack
Arthritis
High Cholesterol
Diabetes
Heart Disease
Back Pain
Stroke
Allergies
Depression
Thyroid Disease
Osteoporosis
Gallstones
Skin Cancer
Heart Failure
Lung Cancer
Migraine
Alcoholism
Emphysema
Alzheimers
Asthma
Breast Cancer
Kidney Disease
COPD
Hepatitis
Rectal Polyps
Other Cancer
Colon Cancer
Seizures
Stomach Cancer
Drug Dependency
Parkinsons
Liver Disease
Uterine Cancer
Prostate Cancer
Ovarian Cancer
AIDS
Liver Cancer

Subject who reported Disease in
Self, Parent or Sibling
88
66
48
42
41
40
36
33
31
31
26
23
22
21
16
16
15
14
12
11
10
10
9
9
9
8
7
7
6
5
4
3
3
2
1
0
0

Percentage
94.6%
70.9%
51.6%
45.2%
44.1%
43.0%
38.7%
35.5%
33.3%
33.3%
27.9%
24.7%
23.6%
22.5%
17.2%
17.3%
16.1%
15.1%
13.0%
11.8%
10.7%
10.7%
9.7%
9.6%
9.6%
8.6%
7.5%
7.5%
6.4%
5.4%
4.3%
3.2%
3.3%
2.2%
1.1%
0%
0%

Subject reported
condition in self
85
55
43
24
17
36
16
28
24
24
23
15
14
6
1
10
6
4
2
7
3
4
5
6
6
3
3
3
1
3
0
2
2
1
0
0
0

Percentage
91.4%
59.1%
46.2%
25.8%
18.3%
38.7%
17.2%
30.1%
25.8%
25.8%
24.7%
16.1%
15.1%
06.5%
01.1%
10.8%
06.5%
04.3%
02.2%
07.5%
03.2%
04.3%
05.4%
06.5%
06.5%
03.2%
03.2%
03.2%
01.1%
03.2%
0%
02.2%
02.2%
01.1%
0%
0%
0%
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Table 6 Health Risk Assessment (HRA)
Dietary Habits, Frequency Distributions, and Percentages
Food Category
Fiber
Vegetables
Meat, Fish, Poultry, Beans
Fruits
Breads, Cereals, Rice, Pasta
Dairy (milk, yogurt, cheese)
Fats, Butter, Oils, Sweets
Salt

Minimum 2 servings/day
76
61
48
48
45
43
40
12

Percentage
81.7%
65.6%
51.6%
51.6%
48.4%
46.2%
43.0%
12.9%

In addition to dietary habits, subjects were asked on the HRA to report their use of tobacco,
including cigarettes and all other forms, such as chewing tobacco, pipe, etc. Reported tobacco use
was minimal, with 71 (88.8%) subjects reporting no tobacco use of any kind and 9 (9.6%)
respondents indicating less than one/half a pack per day. When asked about former habits, 24
subjects (25.8%) reported being former smokers; the average time since quitting was 13.5 years
(across all 24 subjects).
Other information captured on the HRA included details related to existing medications
taken by the subjects. Table 7 presents, in descending order, data on medication usage; it also
includes a list of chronic diseases, and the medications necessary to control those diseases. Subjects
were asked to check all conditions for which they currently take (or are advised to take)
medications.
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Table 7
Health Risk Assessment (HRA) Medication Usage Frequencies and Percentages
Disease/Condition
Hypertension
High Cholesterol
Arthritis
Calcium Supplement
Diabetes
Thyroid Condition
Back Pain
Digestive Problems
Heart Problems
Osteoporosis
Allergies
Asthma
Lung Problems
Seizure
Weight Control

Number of Patients current taking
medication
93
37
31
27
23
21
18
15
15
12
7
7
5
4
2

Percentage
100.0%
39.8%
33.3%
30.3%
24.7%
22.8%
19.4%
16.3%
16.1%
13.0%
7.5%
7.5%
5.4%
4.3%
2.2%

Items which focused on stress levels, exercise, sleep, and preventive health habits were also
included on the HRA. Because this instrument is designed to project an accurate assessment of the
respondents’ risks for negative health consequences, the level of detail and questioning concerning
adherence to preventive health tests is extensive. The HRA section which captures preventive
screening exams includes periodic tests such as mammograms, prostate exams, colonoscopies, etc.
Table 8 displays the respondents’ self-reported history of preventive exams for colorectal disease.
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Table 8 Health Risk Assessment (HRA)
Frequency of screening, percentage, and cumulative percent of exams for colorectal disease
Colorectal Cancer
Screening
Within last year
1 year ago
2 years ago
3-5 years ago
Over 5 years ago
Never

Frequency

Percentage

22
5
8
17
6
35

23.7%
5.4%
8.6%
18.3%
6.5%
37.5%

Cumulative Percent
23.7%
29.1%
37.7%
56.0%
62.5%
100.0%

As Table 8 shows, 44% of respondents indicated that they had not complied with national
guidelines for obtaining a colon cancer screening test within the previous 5 years (based upon
average age of respondents). Interestingly, all 93 (100%) respondents reported a fecal occult blood
test within the previous 5 years, suggesting that perhaps the less invasive test is considered
equivalent, and thus other tests (?) are avoided. Similarly, only 42 (47.2%) of the subjects
indicated they had been screened for Diabetes within the prior 24 months, in spite of the fact that
over 45% reported a history of diabetes within the immediate family. Tables 9 through 12 provide
frequency, percentage and cumulative percent regarding adherence to additional screening
guidelines specific to older men and women, including last mammogram, cervical exams, prostate
cancer screening, and self exams for which nationally recommended guidelines currently exist. The
mammogram and self-exam screening procedures reflect greater compliance rates of the more
unpleasant screening exams such as pap smears and prostate exams.
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Table 9 Health Risk Assessment (HRA)
Preventive Mammogram, Frequency Distributions, and Cumulative Percentages
Last Mammogram

Frequency

Within last year
1 year ago
2 years ago
Over 3 years ago
Never

42
9
10
9
4

Percentage
56.8
12.2
13.4
12.2
5.4

Cumulative
Percent
56.8
69.0
82.4
94.6
100.0

Table 10 Health Risk Assessment (HRA)
Preventive Pap Exam, Frequency Distributions, and Cumulative Percentages
Last Pap Smear

Frequency

Within last year
1 year ago
2 years ago
Over 3 years ago
Never

23
17
11
20
3

Percentage
31.1
23.0
14.8
27.0
4.1

Cumulative
Percent
31.1
54.1
68.9
96.0
100.0

Table 11 Health Risk Assessment (HRA)
Preventive Prostate Cancer Screening, Frequency Distributions, and Cumulative Percentages
Last Prostate Exam

Frequency

Within last year
2 years ago
Over 3 years ago
Never

8
1
5
2

Percentage
50.0
6.2
31.3
12.5

Cumulative
Percent
50.0
56.2
87.5
100.0

Table 12 Health Risk Assessment (HRA)
Preventive Self Exam (Breasts/Testicles), Frequency Distributions, and Cumulative Percentages
Last Self Exam

Frequency

Monthly
Every few months
Rarely/Never
Don’t Know

48
18
20
7

Percentage
51.6
19.4
21.5
7.5

Cumulative
Percent
51.6
71.0
92.5
100.0
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As captured in the HRA data, 56 (60.2%) of the subjects reported that they engaged in some
form of exercise at least 3 times each week. Of these, 44 (47.3%) indicated that they exercise for at
least 20 minutes per exercise session. The exact nature or definition of exercise was not captured. A
more specific exercise question on the HRA, such as strength training, was endorsed by 19 subjects
(20.4%).
Overall, a total of 90 participants (97.8%) reported on the HRA that they always use their
seatbelts. Of those who responded to a similar question of safety behavior on the HRA, 23.2% said
they sometimes drive more than 10 miles over the speed limit.
With respect to sleep, 54 subjects (58.0%) reported on the HRA that they slept fewer than 8
hours per night. Alcohol consumption was minimally endorsed, with 86% of respondents to the
HRA indicating no use of alcohol, and of those who did endorse consumption, 100% indicated at
least 2 drinks per occasion.
Regarding anxiety, 40.5% of respondents to the HRA reported feeling anxious at least 2-3
times per week, but 76.3% endorsed “getting enough emotional support if stressed”.

Factor Analysis of the HABIT
In order to perform a factor analysis of all 50 items on the HABIT questionnaire, the
original study protocol planned to recruit 300 subjects into the study (a multiplier of 6). At the end
of a 4 month recruiting period, a total of 93 subjects had completed participation in the study.
Although this was fewer than desired, the cost of recruiting and testing 93 subjects exceeded
$11,000. The original budget of $10,000 was based upon six weeks of estimated time and labor by
the pharmacist and his staff. In consideration of the time, difficulty, and considerable cost of
recruiting additional subjects, it was jointly decided to end the study with a total of 93 subjects.
Such a limited number of subjects precluded establishing construct validity readily because of low
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subject to item ratio. It was therefore determined that an initial inverse cluster analysis would be
performed to determine Average Linkage between Groups.
The hypothesis presumed that the HABIT questionnaire would produce 8 distinct domains
related to non-adherence. Because of the problem with the subject to item ratio, cluster analysis was
used as an alternative to Factor Analysis of the HABIT. Using the Average Linkage Between
Groups Method, cluster analysis was restricted to 8 clusters. During the cluster analyses the
investigators discovered that 2 interpretable clusters emerged (Cluster 1 with 36 items and Cluster 8
with 3 items). When the clusters were identified, scores were calculated for the clusters, which were
treated as 2 domains. Cluster scores were determined for each subject. There were then 2 scores for
each subject, resulting in an acceptable subject to item ratio. A principal components varimax
rotated analysis according to Kaiser’s criterion was performed. The two clusters merged into one
higher order factor, leading the investigators to the conclusion that Cluster 1 and Cluster 8 loaded on
a single “HABIT Factor”. The HABIT cluster analysis is displayed in Table 13.
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Table 13
HABIT Cluster Analysis

Case
Avoid people who smoke
Try to sleep 8 hours
Avoid cigarette smoke
Watch calories carefully
Test smoke alarms regularly
Obtain tests ordered by my doctor
Take logical approach to problem solving
Examine skin for unusual markings
Wear seat belts in cars
Take all prescriptions as directed by doctor
Eat enough fruits and vegetables
Get enough emotional support if stressed
Limit amount of caffeine consumed
Usually eat 3 meals a day
Avoid excessive use of alcohol
Ask friends not to smoke in my presence
Limit sugar intake
Get prescriptions filled promptly from doctor
Drink low fat or skimmed milk
Examine breasts or testicles for lumps
Get routine physical exams
Successfully cope with most stresses
Keep doctor’s appoints I make
Follow advice of my physician
Limit amount of fat in diet
Able to keep a realistic view of stresses
Am on time for doctor appointments
Take prescribed medication for recommended period
Sit in non-smoking public places
Try to eat low cholesterol foods
Follow doctor’s advice on health matters
Limit salt intake
People tell me I am a couch potato
Do not take prescribed medicines as instructed
Go to bed at regular time each night
Get enough rest each night
Avoid napping in day
Weigh myself on a regular basis
Eat meals while doing other things
Lift weights
Take stairs over elevator or escalator
Don’t chew tobacco
Jog or Run
Practice formal relaxation/medication exercises
Wear sun screen on sunny days
Avoid fast food restaurants
Avoid snacking between meals
Exercise on a regular basis
Prefer to walk rather than drive if possible

8 Clusters
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
3
4
4
4
4
5
5
6
7
8
8
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As displayed in Table 13, Cluster 1 included 36 items. The reliability coefficient of Cluster
1 was .6953 (Chronbach’s Alpha). Items in this Cluster, referred to as the overall Prevention
Cluster, included preventive health habits such as performing routine self exams, getting sufficient
sleep, avoiding tobacco products, eating low fat diets and limiting intake of salt, alcohol, and
caffeine. Items related to coping with stress and following instructions (particularly physician’s
orders) were also included.
Cluster 8 (the second interpretable Cluster), referred to as the Exercise Cluster, included 3
items that were focused on physical exercise, i.e. “I exercise on a regular basis”, “I prefer to walk
rather than drive if possible”, and “I am physically active”. The reliability coefficient of Cluster 8
was .6505 (Chronbach’s Alpha).
Collectively, these 39 items represent a Higher Order Factor. Both Clusters and the Higher
Order Factor revealed a significantly negative correlation with the Overall Health Risk score derived
from the HRA. This leads to the conclusion that the higher the HABIT score, (or the more positive
health behaviors that the subject endorses), the lower his/her overall health risk and the less likely
he/she is to experience hospital stays or to have high blood pressure or other diseases. Specific
correlations between the HABIT and overall health risk (HRA % Risk Score) are displayed in Table
14.
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Table 14
Pearson Inter-correlations between the HABIT, Health Risk Score, Adherence Ratio, and Number of Medications

HRA % Risk Score Pearson Correlation
Sig. (1-tailed)
N
CLUS 1
CLUS 8
ADHRATIO
NUMMEDS
HIORDRNU

Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (t-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N

HRA%
Risk Score
1
.
77

CLUS 1
-.388**
.000
77

CLUS 8
-.400**
.000
77

-.388**
.000
77
-.400**
.000
77
-.054
.321
77
-.088
.228
74
-.437**
.000
77

1
.
93
.398**
.000
93
-.139
.092
93
.048
.328
87
.970**
.000
93

.398**
.000
93
1
.
93
-.123
.121
93
-.047
.334
87
.610**
.000
93

ADHRATIO
-.054
.321
77
-.139
.092
93
-.123
.121
93
1
.
93
.119
.136
87
-.153
.072
93

CLUS 1 = Prevention Cluster
CLUS 8 = Exercise Cluster
ADHRATIO = Adherence Ratio
NUMMEDS = Number of Medications taken
HIORDRNU = Higher Order Factor
HRA % Risk Score = Overall Health Risk result from HRA
** Correlation is significant at the 0.01 level (1-tailed).
* Correlation is significant at the 0.05 level (1-tailed).
As seen in Table 14, Cluster 1 (representing 36 items identified as the Prevention Cluster) is
significantly, negatively correlated (-.388**) to overall Health Risk (HRA % Risk Score). This
strong negative correlation was anticipated on the intuitive hypothesis that a lower risk for disease
and/or poor health would be associated with increasingly positive preventive health behaviors
(higher score on the HABIT). This is consistent with the increasingly significant negative
correlations between Cluster 8 (representing 3 items identified as the Exercise Cluster) and the HRA
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Overall Health Risk Score (-.400**), and the derived Higher Order Factor (HIORDRNU) with the
HRA Overall Health Risk Score (-.437**).
Examining the relationship between the Higher Order Factor of the HABIT and the HRA
Overall Health Risk Score, it is possible to interpret the fact that approximately 19% of the
variability in health risk assessed by the Lifestyle Direction’s Health Risk Assessment (HRA) is
attributable to differences in health behaviors as measured by the Health Adherence Behavior
Inventory (HABIT).

Correlation between the HABIT, the Health Risk Assessment and Biometric Variables
It was predicted that a negative correlation would be reflected between the number of selfreported, positive health behaviors on the HABIT and blood pressure level recorded on the Health
Risk Assessment. This hypothesis was partially supported by a significant negative correlation
between Systolic Blood Pressure and the Higher Order Factor of (-.177*) at a 0.05 significance level
(1-tailed), suggesting that the more positive health behaviors an individual endorses (as reflected on
the HABIT), the lower his/her systolic blood pressure. Table 15 highlights significant correlations
between the HABIT and other variables, including biometric measures and self-reported data offered
by the Health Risk Assessment (HRA). Most notable in these statistics is a significant negative
correlation (-.247**) between the HABIT Factor and self reported servings of fats, butter, oil, and
sweets in a typical day. The subjects who endorsed more healthy behaviors on the HABIT were
less likely to consume excessive calories in fatty foods. There was also a strong negative correlation
between the HABIT Factor and feeling anxious, (-.304**). The more frequently the individual
reported that he/she was anxious, the less likely he/she was to endorse positive health behaviors
presented in the HABIT. A similar significant correlation (-.391**) was found between the HABIT
Factor and the respondent’s last reported colorectal screening exam. Additional similarities were

Non-Adherence

observed between numerous items on the HRA and the HABIT, with statistically significant
correlations. These similarities are presented more fully in the Discussion of this study.

63

Non-Adherence

64

Table 15
Correlations of HABIT with Health Risk Assessment and Biometric Variables
HABIT Cluster 1
Current self rating
of health
Current weight self
reported
No. days hospitalized
for injury in past
12 months
No. days went to ER
due to injury in past
12 months
Systolic Blood
Pressure
No. Servings fats,
butter, oil, sweets
in typical day
Consumption of
fiber in diet
Last screening
for colorectal
cancer
Avg times per
week exercise
Avg times per
week strength
training
How often
you feel
anxious
Avg No.
cigarettes
Per day
Currently
taking Rx
for Diabetes
Currently
taking Rx
for Thyroid

Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N
Pearson Correlation
Sig. (1-tailed)
N

-.158
.066
93
.071
.255
89
-.158
.079
81
-.216*
.025
82
-.177*
.049
93
-.289**
.003
90
-.248**
.008
93
-.391**
.000
89
.251*
.012
80
.163
.140
46
-.304**
.004
74
-.346**
.001
80
-.178*
.044
93
-.190*
.044
93

HABIT Cluster 8
-.252**
.008
92
-.220*
.019
89
.199*
.037
81
.177
.056
82
.117
.136
93
-.054
.308
90
-.051
.314
93
-.228*
.016
89
.426**
.000
80
.256*
.043
46
-.328**
.002
74
-.266**
.009
80
.002
.492
93
-.161*
.061
93

HABIT Higher Order
-.158
.066
92
.071
.255
989
-.158
.079
81
-.216*
.025
82
-.177*
.049
93
-.289**
.003
90
-.248**
.008
93
-.391**
.000
89
.251*
.012
80
.163
.140
46
-.304**
.004
74
-.346**
.001
80
-.178*
.044
93
-.190*
.044
93
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CHAPTER 4
DISCUSSION
Considerable time and effort has been dedicated to the study of non-adherence and to the
implications of this issue for all stakeholders in the healthcare delivery system. The vast majority of
research studies have focused on attempting to understand and to define the key influencers of this
phenomenon. This knowledge has demonstrated utility in the development of specific interventions
which appear to improve adherence, under certain circumstances for various subsets of the
population. Translating this knowledge into a comprehensive set of questions that represent discrete
domains of non-adherence has proven to be more challenging. Given the complexity of the issue of
non-adherence and the number of factors that may influence a particular patient at any given point in
time, it is not surprising that no reliable instrument has yet been developed to predict, with any
accuracy, a given individual’s likelihood of adhering to his or her prescribed treatment by a
healthcare provider. As such, the HABIT represents a new approach to addressing this challenging
issue and the first of its kind to attempt to predict non-adherence based upon a universe of behaviors
not previously observed to be related statistically. The principal research question for this study was
the viability of developing a brief questionnaire which could be used to predict the relative degree of
adherence by a patient with his/her physician’s treatment orders. This was the first study to examine
the validity of the Health Adherence Behavior Inventory as a reliable instrument for this purpose.
The investigators of this study hypothesized that similar patients who are not compliant with
prescribed treatment regimens, specifically adherence to medication, would be identifiable by a
profile of behavioral characteristics captured through a systematic approach of questioning with selfreported responses to a dichotomous questionnaire.
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The findings of this study are interesting because they offer support for the hypothesis that a
finite number of items may ultimately be isolated to offer a practical and efficient approach to
prospectively identifying patients whose health outcomes may be compromised by suboptimal
treatment adherence. The Health Adherence Behavior Inventory offers additional insight about the
specific types of behaviors that appear to be related consistently to overall health. The results
presented in this study suggest that healthier patients do, indeed, engage in or refrain from certain
behaviors which collectively reveal a pattern of habits that correlate significantly with their
individual degrees of health risk. The individuals who endorse greater the number of positive health
behaviors have lower individual overall health risks. Based upon this finding, it would be logical to
expect that the relative risk of poor health would also be correlated significantly with the patient’s
adherence to medication, as measured by an adherence rate or possession ratio. Simply stated,
medication adherence would be viewed as a positive health habit. Thus the less compliant patients
are with treatment (taking their medications), the greater their risk of serious illness and the less
likely they are to endorse other positive health habits. Interestingly, data from this study did not
reveal a statistically significant relationship between the Health Risk Score as calculated by the
Health Risk Assessment and the overall medication adherence ratio. No significant correlation
between the HABIT and overall medication adherence ratio was observed. However, results of this
study did reveal that the HABIT was significantly negatively correlated with a measure of systolic
blood pressure at the 0.05 significance level (-.177*) and significantly negatively correlated at the
0.01 significance level with an overall health risk score as measured by the Health Risk Assessment
(-.437**). The higher the individual scored on the HABIT, the lower their recorded systolic blood
pressure and the relative risk of disease. Investigators concluded that approximately 19% of the
variability of health risk was attributable to differences in health behaviors as measured by the
HABIT.
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Content Validity of the HABIT
The Health Adherence Behavior Inventory was designed to possess content validity. Prior to
implementing the study, a panel of Physician Experts and Psychologists examined these items for
relevance, clarity, and ease of understanding. The Expert Panel members agreed to review the items
and were given the opportunity to revise items. All recommendations from the Expert Panel were
integrated into the final list of items and resubmitted to the Panel for final review. 100% of the
Panel agreed that these items adequately represented the domain of content related to adherence and
health risk behaviors. The Expert Panel included Robert DiTomasso, Ph.D, ABPP, Interim Chair,
Department of Psychology, Director of Clinical Research, Philadelphia College of Osteopathic
Medicine with 25 years of practice as a Psychologist in Primary Care; Harry Morris, D.O., MPH,
with 4 years as Chair Family Medicine and Director of Family Medicine Residency at Philadelphia
College of Osteopathic Medicine with over 20 years practice in Primary Care; James Gamble, M.D.;
and Barbara Golden, Psy.D., Faculty with Department of Psychology, Philadelphia College of
Osteopathic Medicine.

Construct Validity of the HABIT
In order to establish construct validity, the HABIT questionnaire was administered
concurrently with a well documented and validated Health Risk Assessment. A strong correlation
between these two instruments would suggest not only that the construct of the HABIT is sound
insofar as the instruments are purported to have similar utility, but also that the HABIT measures
what it is intended to measure. The Health Risk Assessment algorithm produces a single overall
health risk score. This study found a significant correlation at the 0.01 significance level between
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the health risk score and the HABIT. Additionally, the study of the HABIT has yielded 2 interesting
findings. First, the HABIT questionnaire appears to capture one overall factor or dimension of
health risk. That is, the HABIT represents a single domain of health behaviors that are significantly
correlated with risks for poor health. Although this finding in itself does not offer a comprehensive
set of the domains that influence non-adherence, the emergence of a single domain that correlates
with health risk is important because non-adherence has been found consistently to be a significant
contributor to poor health outcomes and elevated risks. The link between blood pressure control,
health risk, and medication compliance in a hypertensive population is well established. Second, the
absence of a statistically significant correlation between the HABIT and the recorded medication
adherence ratio for these subjects raises worthwhile questions concerning methodological limitations
of this study and introduces opportunities for refinement of the items in future research.

Additional Findings Related to the Health Risk Assessment
As previously discussed, the Lifestyle Directions instrument is a widely used health risk
assessment that has been extensively studied. Thus other significant correlations were evident
during this analysis on an item by item basis. For example, individuals who reported their self
ratings of current health status as good or excellent were significantly more likely to endorse positive
health behaviors and experiences. A positive correlation was noted between self report health status
and satisfactory weight (.253**). Positive health status also correlated with fewer days missed from
work for illness (.226*), and less time spent in the Emergency Room due to illness (.316**).
Subjects who viewed their current health status as positive responded that they watched their caloric
intake (.208*) and exercised more frequently (.374*) than those who reported a poorer health status.
A positive attitude about health also correlated with self reported preventive exams, such as
colonoscopy (.463*).
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Overweight subjects were more likely to endorse poorer health habits, and indicated lower
overall self ratings of their current health. Being overweight was negatively correlated with each of
the following behaviors: exercise (-.303**), consumption of fruits and vegetables (-.185*), taking
medication for hyperlipidemia (-.277**), and HDL, or good cholesterol (-.332**). Being
overweight was also positively correlated with alcohol consumption (.482*), diastolic blood pressure
(.215*), and consumption of fats and sweets (.392*).
Waist circumference was positively correlated to several poorer indications of health,
including higher number of visits to a physician (.427*), days hospitalized (.444*), Emergency
Room visits (.593**), Systolic Blood Pressure (.518*), Total Cholesterol (.590*), and LDL (.608*).
The number of medications that an individual was taking correlated significantly with the
frequency of physician visits (.647**), reflecting a greater need to see a doctor when on chronic
medications. Frequency of physician visits also correlated positively with the frequency of
prescription refills (.217*), suggesting, perhaps, that the more an individual goes to the doctor the
greater the likelihood that he or she will fill prescriptions.
Hospitalizations were significantly correlated with several biometric measures of acute
health issues, including high triglycerides levels (.315**), fasting glucose levels, (.981**), and fat
intake (.194*). Negative correlations between frequency of hospitalizations and self-reported
medication compliance were observed in the following disease conditions: asthma (-.325**), heart
conditions (-.201*), digestive disorders (-.208*), lung disease (-.385**), osteoporosis (-.222*), and
smoking-.410*).
Systolic blood pressure was positively correlated with diastolic blood pressure (.306**), and
random glucose (.248*). A negative correlation between systolic blood pressure and health behavior
was also observed, including a negative correlation with self reported compliance with diabetes
medication (-.245*) and cholesterol prescriptions (-.203*). Many participants who reported
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currently taking medication to control blood pressure also reported higher servings of fats and sweets
(.209*).
Diastolic Blood Pressure (DBP) was positively correlated to LDL, or bad cholesterol, at
(.342**). A higher DBP was also correlated with increased frequency of prescription (days
prescribed) at (.219*). Stated another way, those individuals with higher diastolic blood pressure
readings were more likely to receive prescriptions.
HDL, or good cholesterol was negatively correlated to the following metrics:
weight, (-.332*), waist circumference (-.494*), triglycerides (-.315*), and blood pressure ratio
(-.961**). Triglycerides were positively correlated to fat intake (.213*), blood pressure ratio
(.893*), cholesterol (.471**).
Fasting glucose was significantly correlated to daily servings of cheese and dairy products
(.874*). Servings of fruit consumed daily was negatively correlated to weight (-.185*), waist
circumference (-.511**), caloric intake (-.183*), fat intake (-.263**), and consumption of fiber (.302**). Fruit consumption was positively correlated to vegetable intake (.617**), dairy foods
(.346**), and poultry and rice (.341**).
Fat intake was positively correlated with total caloric intake (.680**), as well as with the
number of days prescribed medication (.319**). Fat intake was also associated with frequently
driving over the speed limit (.243*). Fats and sweets intake was positively correlated with level of
anxiety (.283**). Total caloric intake was negatively associated with self reported compliance with
cholesterol medication (-.278*) but positively correlated with the number of days prescribed
medication (.197*). Drinking alcohol was similarly associated with higher average weight (.575**).
Those with higher reported fat intake endorsed higher caloric intake (.197*), and reported that they
more frequently drove over the speed limit (.273*).
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Smoking was negatively correlated with resting pulse rate (-.763**) as was alcohol
consumption (-.800**). A negative correlation was found between the number of cigarettes per day
and Cluster 1 of the HABIT (-.346**); significant correlation was also found between cigarettes and
Cluster 8 of the HABIT (-.266*). Cigarette smoking was negatively correlated with self reported
medication compliance (-.234*), as well as with weight (-.575**).
There was a strong correlation between last mammogram and last pap smear (.356**) as
well as the last pap smear and colonoscopy (.347*). There was a negative correlation between
anxiety and exercise (-.325*). Preventive self exam of testicles was associated with higher
prescription refill rates (.631**). Self reported attitudes about exercise, stress, nutrition, weight, and
drinking were all significantly correlated. A positive attitude about stress and strong coping
strategies were associated with healthier attitudes towards weight management (.413**), nutrition
(.752**), exercise (.680**), smoking (.708**), and alcohol (.613**). A positive attitude about
exercise was associated with a positive attitude about smoking (.688**) and alcohol (.696**).
Likewise, a positive attitude about nutrition and diet management was associated with a positive
attitude towards exercise (.667**), stress (.752**), smoking (.706**), and alcohol (.649**).
Certainty about maintaining health, or self efficacy, was negatively correlated with random glucose
(-.276*), and fat intake (-.256*). It was also positively correlated with preventive exams such as
colonoscopy (.463**) and cancer screenings (.279*).
Those who reported currently taking medication to control cholesterol reported higher
servings of fats and sweets (.184*). These individuals also reported a greater number of medications
for associated heart disease (.304**) and thyroid disease (.244**).
There were several correlations between individuals’ self reported compliance with asthma
medications and other variables. Specifically, individuals who reported that they that complied with
asthma medication made fewer visits to the doctor (-.289**), made fewer visits to a hospital (-
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.325**), spent fewer days in the hospital (0.247**), experienced fewer days missed from work or
other activities (-.262**), and made fewer trips to the Emergency Room (-.261*). The more
compliant the subjects were with asthma medications the more compliant they reported themselves
with other medications, such as those for osteoporosis (.290**), lung disease (.655**), allergies
(.537**), and weight control (.520**).
A positive attitude about nutrition correlated to higher refills of prescriptions (.379**). Less
anxious individuals endorsed more positive health behaviors on the HABIT (-.304**), and less
tobacco use (-.346**). Total blood cholesterol was correlated to triglyceride levels (.893*), but
negatively to HDL (-.315**), and positively correlated to fat intake (.213*). HDL was negatively
correlated to alcohol (-.654*), and certainty amount maintaining(???) health was correlated to
random glucose (-.276*).
These findings suggest the need for future research on related variables of interest.

Internal Consistency of the HABIT
In order to assess the internal consistency of the HABIT scores, Chronbach’s coefficient
alpha reliability was calculated. The coefficient alpha of the entire scale was .705.

The Dimensions of Non-Adherence
The findings from this study of the HABIT appear to uncover two basic types of behaviors
that are related to health risk. The first set of behaviors is somewhat passive in nature; however, the
second set of behaviors may be described as more proactive in nature. For discussion purposes, the
first cluster of statements is referred to as the “prevention cluster” and the second cluster of
statements is referred to as the “exercise cluster”. Behavior statements that were endorsed in the
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prevention cluster included phrases like “avoid people who smoke”, “avoid excessive use of
alcohol”, “avoid napping in the day”, “avoid fast food restaurants”, “ “avoid snacking”, “limit
caffeine”, “limit sugar”, “limit fat”, “limit cholesterol foods”, and so forth. Behaviors statements
that were endorsed in the exercise cluster, though limited, included the phrases “I exercise on a
regular basis”, “I prefer to walk rather than drive if possible”, and “I am physically active”. Initial
consideration was given to the value of interpreting these clusters as representing different “themes”.
For example, could exercise be considered a more proactive behavior, requiring more motivation on
behalf of the subject and therefore be more predictive, whereas avoidance behaviors require less
effort? With such small numbers, a reliable answer to this question could not be determined;
however, the subtle difference suggests that further research to assess these behaviors as independent
domains may be fruitful.
Collectively, based upon this sample size, both clusters were determined to represent a single
factor or dimension of non-adherence, which was jointly referred to as the “HABIT Factor”; this
factor was determined to account for 19% of the variability in health risk as calculated by the HRA.
In an effort to understand how the behaviors reported on the HABIT were related to the Adherence
Ratio, further investigation of the raw data revealed interesting findings with respect to certain
responses. Specifically, when the frequency distribution of the Days Fill Ratio (numerator and
denominator) was examined, it was apparent that 83 of the 93 subjects (89.2%) had an
antihypertensive prescription written for a full calendar year (365 days). The remaining 10 subjects
had a prescription written for at least 6 months. Yet the corresponding prescription fill rate (number
of days for which the patient actually had medication), was far less in most cases. In fact, none of
the subjects had sufficient medication for the entire prescribed period, and 34 patients (36.6%) had
fill rates of less than 50%. This information was reliable, based upon the pharmacy records and
patients’ self-reported use of a single pharmacy for filling all prescriptions. This is consistent with
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the literature on medication adherence rates, but not generally considered acceptable for therapeutic
efficacy. Another 8 patients (8.6%) had filled their prescriptions 65.7% of the time, and 13 patients
(13.9%) had a minimum supply of 270 days (73.9% Days Fill Ratio). Roughly expressed, a
handful of patients had missed only 2 days of medication each week, or 8 days per month, yet
another 42 (45.1%) patients failed to take the prescribed medication between 34.2% and 100% of
the time. Less than 28% of the subjects missed fewer than 6 days per month medication.
Self-reported responses captured by the HABIT were not subject to verification; however,
results indicated that 96.8% of the 93 subjects in the study reported that they got their prescribed
medications filled promptly, and 94.6% of them indicated that they took prescribed medications for
the recommended period. When asked about following their doctor’s advice, 93.5% said they
followed their doctors’ advice on matters related to their health.
One possible explanation for the observed discrepancy is a desire to “fake good”. All of the
participants in this study were, by definition, diagnosed with hypertension. In addition, 85 of the 93
subjects reported experiencing a previous heart attack. One consideration is that this could represent
a bias in the population which may be reflected in distorted perceptions of actual adherence. Given
that 83 of the subjects had been diagnosed with hypertension for more than a year, it is not
unreasonable to assume that many of the subjects have had their blood pressures monitored by their
physicians for some time. In fact, they may well have had serious discussions with their physicians
related to their conditions. To admit that they were not taking medication or were not following
their physicians’ advice might have resulted in cognitive dissonance and subsequent distorted
perceptions of their own behaviors.
The Health Risk Assessment does not contain items specific to medication compliance. The
respondent is simply asked to check from a list of conditions for which they are currently taking a
medication. The presence of a condition is utilized in the health risk algorithm, but compliance is
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not. Quantitative measures such as age, weight, and lab values weigh more heavily in the
calculation than qualitative responses. As a result, there is little opportunity to “fake good” on the
Health Risk Assessment.
As previously mentioned, numerous theories have been offered to explain why one person
will adhere to his/her physician’s advice and another person will not. Some of the factors proposed
as influencing adherence include the nature of the condition or disease, the complexity of the
treatment regimen, and individual psychological characteristics. These theories are useful to
establish hypotheses about the rationale for behavior, but the majority of research in this area does
not expand on the types of behaviors observed by compliant or non-compliant patients. The most
common tool at the disposal of healthcare professionals and health insurance plans remains the
retrospective claims analysis. This type of automated analysis utilizes claims databases to identify
diagnosed patients who, based upon quantitative data, appear to be non-adherent with medication or
other prescribed treatment guidelines. Interventions can then be targeted to these individuals, and
often include case management, patient education or compliance reminder mailings, etc.
Additional reasons posited for non-adherence are external or situational factors, such as the
relative cost and the patient’s access to medical care. Studies examining these factors contribute to
the literature by offering additional insight into the dimensions and behavior which correlate with
poor patient adherence and by offering further evidence that these factors correlate with overall
health risk. Further research with larger and more diverse study populations may support the
development of a limited number of questions representing a comprehensive set of domains that
correlate with non-adherence. This may ultimately allow for the development of patient profiles that
could facilitate the identification of critical targets for treatment in non-adherent patients. In
practice, if the instrument is refined, prudent use of the HABIT may enable the clinician to improve
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therapeutic outcomes through earlier intervention in which patient behaviors may compromise
overall treatment.

Methodological Limitations of the Study
There are several limitations to the current study, including those that are specific to this
study and those that are more universal. In general, self-reports are influenced by the wording of the
questions, content, and format. As a result, the subjects who participated in this study may have
interpreted the questions differently. They may also have been more or less motivated to respond is
ways that would be socially desirable. The questions on the HABIT deal with personal health
behaviors that may be associated with an individual’s perception of “character”. The nature and
structure of the questions and the relative transparency of the content make it possible to overstate a
response, and thus increase (?) the overall degree of its importance. There are no right or wrong
answers and no direct way to assess the patient’s subjective state independently. Bias and
inaccuracy can be additionally compromised by the rapport with the clinician and by the physical
conditions (such as medication or food immediately prior to a biometric screening).
Another limitation of this study concerns the demographics of the population. The
volunteers were, on average, older subjects and predominantly female. This resulted in a higher
than anticipated number of seniors whose health, based upon age alone, would be expected to be at
greater risk for serious illness. This was most evident in the percentage of individuals who reported
a previous heart attack (91.4%). The co-morbidities, health insurance benefits, and seriousness of
overall health conditions reflected in this population would not necessarily be representative of the
general population; this results in findings that necessitate further investigation.
These deficiencies negate neither the overall value of the HABIT questionnaire nor the
relative contributions of this study. The correlation between the HABIT and the Health Risk
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Assessment suggest that the current version of the HABIT may provide a cost effective alternative to
other assessments that are underutilized due to length, cost, and complexity.
By removing those items that do not load on the single habit factor, and by refining the
remaining items into a smaller subscale, it may be possible to construct a more comprehensive
questionnaire that addresses additionally relevant domains of non-adherence. Specifically, several
questions related to following physician’s advice and obtaining medication are similar in wording
and the data from this study revealed nearly identical responses. New research on application of the
Transtheoretical Model and Health Belief Model is underway for the explicit purpose of developing
interventions to improve adherence. These studies are more narrowly focused on the concept of selfefficacy and stages of change as they relate to distinct profiles of non-adherent individuals. The
relative utility of segregating persons of similar beliefs into categories of non-adherence, i.e. nonadherers, partial adherers, and near-optimal adherers, may also provide additional insight as to the
behavioral characteristics that make these groups unique. Additionally, restructuring the HABIT
questions into a Likert scale may offer greater sensitivity to capture subtle differences less evident in
a dichotomous format.

Implications for Research and Future Direction
It is clear that many factors operate to impact adherence and that these factors vary not only
across demographics and individuals, but also across illnesses. The reliability of future research
may be challenged by errors of measurement that may take place due to problems such as
inconsistency of examinees (e.g., motivation, interest, and attention), flaws in research design,
testing site differences, and distractions. Other challenges may necessitate modification of the items
to lessen the transparency of questions. One possibility is to utilize another instrument such as an
acceptable measure of social desirability to assess the impact of this issue.
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Conclusions
The HABIT questionnaire shows promise in capturing reliable information that correlates with nonadherence. Specifically, a selection of self reported health behaviors appear to be linked to health
risk in ways that offer partial explanations and predictions which account for variability in health
outcomes. These behaviors represent one dimension of non-adherence that is relatively easy
information to collect and assess. Numerous theories and research on non-adherence have proposed
both internal and external factors as critically influential in determining treatment adherence.
Further work is necessary to incorporate the learnings from this study into future research which
applies theoretical concepts to expand the universe of predictable behaviors.
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Addendum: Combination Drugs for Hypertension

Combination Type

Fixed-Dose Combination, mg

Trade Name

ACEIs and CCBs

Amlodipine/benazepril hydrochloride
(2.5/10, 5/10, 5/20, 10/20)
Enalapril maleate/felodipine (5/2.5, 5/5)
Trandolapril/verapamil (2/180, 1/240,
2/240, 4/240)
Benazepril/hydrochlorothiazide (5/6.25,
10/12.5, 20/12.5, 20/25)
Captopril/hydrochlorothiazide (25/15,
25/25, 50/15, 50/25)
Enalapril maleate/hydrochlorothiazide
(5/12.5, 10/25)
Lisinopril/hydrochlorothiazide
(10/12.5, 20/12.5, 20/25)
Moexipril HCI/hydrochlorothiazide
(7.5/12.5, 15/12.5, 15/25)
Quinapril HCI/hydrochlorothiazide
(10/12.5, 20/12.5, 20/25)

Lotrel
Lexxel
Tarka

ACEIs and diuretics

Lotensin HCT
Capozide
Vaseretic
Prinzide
Uniretic
Accuretic

Non-Adherence
ARBs and diuretics

BBs and diuretics

Centrally acting drug and diuretic

Diuretic and diuretic

Candesartan
cilexetil/hydrochlorothiazide (16/12.5,
32/12.5)
Eprosartan
mesylate/hydrochlorothiazide
(600/12.5, 600/25)
Irbesartan/hydrochlorothiazide
(150/12.5, 300/12.5)
Losartan potassium/hydrochlorothiazide
(50/12.5, 100/25)
Olmesartan/hydrochlorothiazide
(20/12.5, 40/12.5, 40/25)
Telmisartan/hydrochlorothiazide
(40/12.5, 80/12.5)
Valsartan/hydrochlorothiazide (80/12.5,
160/12.5, 160/25)
Atenolol/chlorthalidone (50/25, 100/25)
Bisoprolol
fumarate/hydrochlorothiazide (2.5/6.25,
5/6.25, 10/6.25)
Propranolol/hydrochlorothiazide
(40/25, 80/25)
Propranolol LA/hydrochlorothiazide
(80/50, 120/50. 160/50)
Metoprolol tartrate/hydrochlorothiazide
(50/25, 100/25, 100/50)
Nadolol/bendrofluthiazide (40/5, 80/5)
Timolol maleate/hydrochlorothiazide
(10/25)
Methyldopa/hydrochlorothiazide
(250/15, 250/25, 500/30, 500/50)
Reserpine/chlorothiazide (0.125/250,
0.25/500)
Reserpine/hydrochlorothiazide
(0.125/25, 0.125/50)
Amiloride HCI/hydrochlorothiazide
(5/50)
Spironolactone/hydrochlorothiazide
(25/25, 50/50)
Triamterene/hydrochlorothiazide
(37.5/25, 75/50)

Atacand HCT
Teveten HCT
Avalide
Hyzaar
Benicar HCT
Micardis HCT
Diovan HCT

Tenoretic
Ziac
Inderide
Inderide LA
Lopressor HCT
Corzide
Timolide

Aldoril
Diupres
Hydropres

Moduretic
Aldactazide
Dyazide, Maxzide

ACEI = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker; BB = beta-blocker; CCB =
calcium channel blocker.
Source: http://www.nhlbi.nih.gov/guidelines/hypertension/express.pdf; 9-12-03 and current PIs.
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